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ABSTRACT 
 
ENCAPSULATION OF CURCUMIN IN O/W NANOEMULSIONS AND ITS 
BIOACCESSIBILITY AFTER IN VITRO DIGESTION 
 
SEPTEMBER 2010 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor H. Xiao 
 
The functional ingredient curcumin has a variety of biological and pharmacological 
actions, such as anti-tumor, anti-inflammatory, anti-virus, anti-oxidant, and anti-HIV 
properties coupled with low toxicity. However, curcumin possesses low bioavailability 
due to its poor solubility in water. The purpose of this study was to investigate the impact 
of different lipid-based formulations of curcumin on in vitro solubilization and 
bioaccessibility. Oils representing LCT, MCT, LCT:SCT mix and SCT were used to 
prepare O/W (nano)emulsions with droplet sizes as low as 174 nm. An in vitro digestion 
model simulating the small intestine milieu in the fasted and fed state was used to 
characterize rate, extent, and particle size associated with emulsion digestion. Rate and 
extent were oil dependent, but not particle size. SCT emulsions digested at the fastest 
initial rate, but MCT emulsions were digested to the largest extent. Bioaccessibility, a 
precursor to eventual bioavailability, was determined after digestion using a 
curcumin:lipid content dependent and independent method. MCT produced the highest 
bioaccessibility of curcumin for each method. Nanoemulsion digestion and 
bioaccessibility results were compared to conventional emulsions because an appropriate 
comparison was needed to determine the merits of the nanoemulsion delivery system. 
There was no significant difference in particle size and bioaccessibility between the 
conventional and nanoemulsions. 
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CHAPTER 1 
 
LITERATURE REVIEW 
1.1 General Information of Curcumin 
 
 Curcumin, 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, is a 
natural polyphenolic phytochemical extracted from the powdered rhizomes of the spice 
turmeric (Curcuma longa) (Khanna 1999). It constitutes approximately 3-4% of the 
composition of turmeric. Along with the other curcuminoids, curcumin is responsible for 
the yellow color of turmeric. Turmeric is prominently used in South and East Asian 
countries for culinary, medicinal, and cultural uses. As an additive, turmeric can improve 
the palatability, aesthetic appeal, and shelf life of perishable food items. In the Ayurvedic 
system of medicine, turmeric is used as a tonic, blood purifier, and topical ointment (Joe, 
Vijaykumar et al. 2004).  
Curcumin can exist in at least two tautomeric forms, diketo and keto-enol. The 
structures are seen in Figure 1 (Kolev, Velcheva et al. 2005): 
 
Diketo Form 
 
 
Keto-Enol Form 
 
Figure 1: Diketo and keto-enol forms of curcumin. 
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The keto-enol form is strongly favored by intramolecular H-bonding and is more 
energetically stable in the solid phase and in solution (Roughley and Whiting 1973; 
Pedersen, Rasmussen et al. 1985; Tonnesen 1991; Litwinienko and Ingold 2004). The 
central β-diketone moiety is suggested to be likely responsible for the high beneficial 
activities of curcumin mentioned above (Osawa and Namiki 1985; Ruby, Kuttan et al. 
1995).  
1.2 Potential Biological Properties of Curcumin 
 
The structure of curcumin is important to its proposed biological properties and 
beneficial effects. The central β-diketone moiety is suggested to be likely responsible for 
the high beneficial activities of curcumin (Osawa and Namiki 1985; Ruby, Kuttan et al. 
1995; Sreejayan and Rao 1996; Sreejayan and Rao 1997). The enol form is more 
energetically stable in the solid phase and in solution. The dried rhizome of the Curcuma 
longa plant is very rich in phenolics, with curcumin included. Curcumin has attracted 
considerable attention in recent years due to its great variety of beneficial biological and 
pharmacological activities (Duvoix, Blasius et al. 2005)  
Curcumin has been found to have anti-inflammatory (Joe and Lokesh 1994; Joe 
and Lokesh 1997; Joe, Rao et al. 1997; Chan, Huang et al. 1998; Joe and Lokesh 2000), 
anti-oxidant (Sharma 1976; Joe and Lokesh 1994; Sreejayan and Rao 1996), anti-tumor 
(Huang, Lou et al. 1994; Lin, Chen et al. 1997); (Gescher, Pastorino et al. 1998; Khar, 
Ali et al. 1999; Chuang, Cheng et al. 2000; Chuang, Kuo et al. 2000; Dorai, Cao et al. 
2001), anti-mutagenic (Anto, George et al. 1996), anti-fungal (Bartine and Tantaoui-
Elaraki 1997), and anti-viral (Barthelemy, Vergnes et al. 1998) properties. 
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1.3 Bioavailability of Curcumin and Current Approaches for its Delivery 
 
The term bioavailability is defined as the fraction of an ingested component that 
eventually ends up in the systemic circulation (Versantvoort, Oomen et al. 2005).  The 
overall bioavailability (F) of poorly water-soluble lipophilic components depends on a 
number of physicochemical and physiological factors, as signified in Equation 1: 
F = FB × FA × FM          (1) 
Here, FB is the fraction of lipophilic component released from the food matrix into the 
juices of the gastrointestinal tract to become bioaccessible, FA is the fraction of the 
released component that is absorbed across the intestinal epithelia, and FM is the fraction 
of the absorbed component that reaches the systemic circulation without being 
metabolized.  The major physicochemical and physiological processes that determine 
these parameters for lipophilic components have been identified (Bermudez, Pacheco et 
al. 2004; Fave, Coste et al. 2004; Bauer, Jakob et al. 2005): 
• Bioaccessibility:  A poorly water-soluble lipophilic component must be released 
from the food matrix and solubilized within mixed micelles present in the small 
intestine before it can be absorbed.  These mixed micelles consist of bile salts and 
phospholipids secreted by the body, as well as lipid digestion products 
(monoacylglycerides and free fatty acids).  The solubilization step therefore 
determines the fraction of lipophilic component that is bioaccessible (FB). 
• Absorption: The mixed micelles transport the solubilized lipophilic components 
across the intestinal lumen, through the mucous layer (“unstirred layer”), and to the 
surface of the intestinal enterocyte cells.  The lipophilic components are then 
incorporated into the enterocyte cells through either a passive or an active 
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mechanism (Singh, Ye et al. 2008).  This step determines the fraction of the 
solubilized lipophilic component that is absorbed (FA) by the body. 
• Metabolism: Once the lipophilic component has been incorporated into the 
enterocyte cells it is transported to the systemic circulation by a route that depends 
on the chemical nature of the lipophilic component.  High molecular weight 
lipophilic components tend to be transported via the lymphatic route, whereas short 
and medium molecular weight lipophilic components tend to be transported via the 
portal vein and liver.  Lipophilic components are often metabolized when they pass 
through the liver before reaching the systemic circulation.  The pathway that the 
lipophilic component is transported to the system circulation therefore determines 
the fraction of the lipophilic component that survives metabolism (FM).  
A graphic representation is seen in Figure 2 (Porter, Trevaskis et al. 2007): 
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Figure 2: Potential effects of lipids on drug absorption. Lipids can affect drug 
absorption in three ways: by enhancing drug (D) solubilization in the intestinal milieu 
through alterations to the composition and character of the colloidal environment — for 
example, vesicles, mixed micelles and micelles (a); by interacting with enterocyte-based 
transport and metabolic processes, thereby potentially changing drug uptake, efflux, 
disposition and the formation of metabolites (M) within the enterocyte (b); or by altering 
the pathway (portal vein versus intestinal lymphatic system) of drug transport to the 
systemic circulation — which in turn can reduce first-pass drug metabolism as intestinal 
lymph travels directly to the systemic circulation without first passing through the liver 
(c). Cellular junctions are represented by green ovals and a representative transport 
protein is depicted by a blue oval. 
 
In Figure 2, parts a, b, and c are equivalent to bioaccessibility, absorption, and 
metabolism, respectively.  
A lack of information regarding the mechanism of action of curcumin and its low 
bioavailability have resulted in low amounts of clinical use in western countries (Joe, 
Vijaykumar et al. 2004). A prominent reason for its low bioavailability is that curcumin is 
virtually insoluble in water at acidic or neutral pH (Maiti, Mukherjee et al. 2007). The 
maximum solubility reported was 11 ng/mL in plain aqueous buffer (Tonnesen, Masson 
et al. 2002). Another problem is that curcumin, after oral dosing, undergoes rapid 
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degradation and molecular fragmentation to several reduced products (Wang, Pan et al. 
1997; Pan, Huang et al. 1999; Lin, Pan et al. 2000; Ireson, Orr et al. 2001). Thus, 
curcumin’s use as a therapeutic agent suffers from many shortfalls. 
 Several approaches have been investigated to improve the bioavailability of 
curcumin. Specific approaches have included loading curcumin into liposomes or 
nanoparticles (Anand, Kunnumakkara et al. 2007; Marczylo, Verschoyle et al. 2007; 
Mukerjee and Vishwanatha 2009; Anand, Nair et al. 2010) and interacting curcumin with 
polysaccharides (Tonnesen, Masson et al. 2002), and phospholipids (Liu, Lou et al. 2006; 
Maiti, Mukherjee et al. 2007). 
 Anand et al., (2010) employed a polymer-based nanoparticle approach to improve 
the bioavailability of curcumin. The focus of their study was to prepare and characterize 
the curcumin nanoparticles using various methods, with a goal to enhance its 
bioavailability without loss of biological activity. Curcumin was encapsulated in 
biodegradable nanoparticulate formulation based on poly (lactide-co-glycolide) (PLGA) 
and a stabilizer polyethylene glycol (PEG)-5000. Dynamic laser light scattering and 
transmission electron microscopy indicated a particle diameter of 80.9 nm. These 
nanoparticles were examined for cellular uptake, the ability to induce apoptosis and 
suppress proliferation of tumor cells, suppression of NF-kB and NF-kB-regulated gene 
products, and in vivo bioavailability. For most studies, human leukemia KBM-5 cells 
were used, as the effects of curcumin on these cells have been well described. The 
nanoparticle curcumin treatment was compared to native curcumin for this study and the 
treatment showed a greater efficacy than native curcumin for the attributes listed. 
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 Mukerjee and Vishwantha (2009) formed poly (lactic-coglycolic acid) (PLGA) 
nanospheres using a solid/oil/water emulsion solvent evaporation method to encapsulate 
curcumin. In the nanosphere formulation process, the polyvinyl (PVA) solution acted as 
the stabilizer and the ethanol acted as the nonsolvent. Briefly, 30 mg of the polymer 
PLGA, was dissolved in chloroform. Free curcumin was added to the PLGA/chloroform 
solution and sonicated at 55 W for 1 minute to produce the s/o primary emulsion. This 
emulsion was then added to a solution of 2% PVA and ethanol (1:1) and again sonicated 
at 55 W for 2 minutes to form the final s/o/w emulsion. The particle size distribution 
showed a range of 35 nm to 100 nm, with the mean particle size being 45 nm. 
Characterization of the nanospheres was done by particle size analysis, encapsulation 
efficiency, percent yield, and various microscopy methods. They investigated the ability 
of these nanospheres to be endocytosed by cells, specifically the cancer cell lines, 
DU145, PC3 and LNCaP. These were incubated with curcumin-loaded Nile red-labeled 
PLGA nanospheres for three hours and results depicted robust uptake of the nanospheres 
in all three prostate cancer cell lines. 
 Marczylo et al., (2007) produced a formulation of curcumin with soy 
phosphatidylcholine-phospholipid complex called “Meriva” in Europe to enhance 
systemic bioavailability of curcumin in male Wistar rats following oral gavage. The 
preparation of Meriva used EpiKuron130 P, a de-oiled, powdered soybean lecithin 
enriched with 30% phosphatidylcholine. Peak plasma levels and area under the plasma 
concentration time curve (AUC) values for parent curcumin after administration of 
Meriva were 5-fold higher than those seen after administration of unformulated 
curcumin. Similarly, liver levels of curcumin were higher after administration of Meriva 
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as compared to unformulated curcumin. In contrast, curcumin concentrations in the 
gastrointestinal mucosa after ingestion of Meriva were somewhat lower than those 
observed after administration of unformulated curcumin. Similar observations were made 
for curcumin metabolites as for parent compound. Extracts of bio-matrices were 
subjected to HPLC mass spectrometric analysis and the analysis furnished 
incontrovertible proof of presence of curcumin based on specific MRM transitions in the 
gut mucosa, plasma, and liver. The results suggested that curcumin formulated with 
phosphatidylcholine furnished higher systemic levels of parent agent than unformulated 
curcumin. 
 Tonnesen et al., (2002) complexed curcumin with a variety of cyclodextrins in 
order to improve its stability and retard the degradation process. Cyclodextrins were used 
as pharmaceutical excipients, mainly as solubilizing and stabilizing agents for lipophilic 
substances in aqueous preparations. A number of molecules were solubilized in 
cyclodextrin solutions through formation of an inclusion complex. The cyclodextrins 
used to encapsulate curcumin were hydroxypropyl-α-cyclodextrin, hydroxypropyl-β-
cyclodextrin, hydroxypropyl-γ-cyclodextrin, randomly methylated β-cyclodextrin, 
sulfobutylether-β-cyclodextrin, and hydroxytrimethylamoniumpropyl-β-cyclodextrin. 
The water and lytic stability of curcumin in the cyclodextrin complexes was determined 
and found to be superior to curcumin in organic solvent systems. However, the 
photostability was greatly diminished in these complexes. 
 Maiti et al., (2007) produced a formulation of curcumin with hydrogenated soy 
phosphatidyl choline (HSPC) to improve its therapeutic efficacy, overcome the limitation 
of absorption, and to investigate the protective effect of curcumin–phospholipid complex 
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on carbon tetrachloride induced acute liver damage in rats. The complex was prepared 
with curcumin and HSPC at a molar ratio of 1:1. The mixture was refluxed at a 
temperature not exceeding 60 ºC for 2 h. The curcumin–phospholipid complex was 
precipitated and the precipitate was filtered and dried under vacuum to remove traces of 
solvents. The complex’s yield was 88% weight/weight basis. The complex’s antioxidant 
activity in carbon tetrachloride intoxicated rats was found to be greater than that of pure 
curcumin using the thiobarbituric acid reactive substance (TBARS), superoxide 
dismutase (SOD), and catalase (CAT) tests. Free curcumin at the dose of 200 mg/kg 
prevented the adverse conditions in rats created by CCl4 intoxication. The complex also 
restored the normal condition of rat liver enzymes.  
1.4 Nanoemulsion Approach to Curcumin Encapsulation 
 
Emulsions are mixtures of two or more immiscible liquids. Many bioactive 
components or ingredients are not soluble in water. In an emulsion-based delivery 
system, the component, in my case a lipophilic component, can be first dissolved into an 
oil phase and then emulsified with a water phase to make a homogenous emulsion. These 
systems have been widely used in the food industry to protect active ingredients against 
extreme conditions, to enhance their stability, to maintain their effectiveness, and to mask 
bad odors and bitter taste (Madene, Jacquot et al. 2006). 
However, emulsions are subject to various destabilization mechanisms such as 
gravitational separation, coalescence, flocculation, sedimentation, creaming, and Ostwald 
ripening. The small droplet size of nanoemulsions makes them resistant to physical 
destabilization via gravitational separation, flocculation and/or coalescence due to 
effective steric stabilization (Capek 2004; Tadros, Vandamme et al. 2004; Solans, 
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Izquierdo et al. 2005). Several phytochemicals have already been encapsulated using 
nanoemulsions (Garti 2005). 
Nanoemulsions, as a lipid-based solubilized drug formulation, can enhance drug 
solubilization within the GI tract by avoiding solid-state limitations of the drug and 
increasing solubilization capacity via enhanced secretion of biliary-derived solubilizing 
compounds (Porter, Trevaskis et al. 2007). Micelles, and other digestion products such as 
vesicles and liposomes, are formed from free fatty acids that have evolved from the 
digestion of triglycerides. Nanoemulsions, by increasing the solubility of a hydrophobic 
compound like curcumin, can enhance the absorption in the gastrointestinal tract (Patel 
and Sawant 2007).  
Recently, different variations of emulsion-based delivery systems have been used 
(Bisht, Feldmann et al. 2007; Wang, Jiang et al. 2008; Cui, Yu et al. 2009; Lin, Lin et al. 
2009) with curcumin. These systems can produce nanoemulsions with droplet sizes from 
50-200 nm and microemulsions with droplet sizes less than 20 nm. Conventional 
emulsions have a size range from 1-100 µm. Nanoemulsions possess high kinetic stability 
due to their extremely small emulsion droplet sizes in the range of 50-200 nm 
(Sonneville-Aubrun, Simonnet et al. 2004; Solans, Izquierdo et al. 2005).  
Cui et al., (2009) utilized a self-microemulsifying drug delivery system 
(SMEDDS) to improve the solubility and oral absorption of curcumin. Variable 
proportions of oil, surfactant and co-surfactant were added into a 10ml screw-capped 
glass tube, and the components were mixed by gentle stirring. After complete dissolution, 
SMEDDS, a clear and transparent solution, was obtained. The optimal microemulsion 
formulation was determined by pseudoternary phase diagrams and consisted of oil (ethyl 
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oleate), surfactant (emulsifier OP: Cremorphor EL = 1:1 w/w), co-surfactant (PEG 400) 
and water. The average particle size of the curcumin-loaded SMEDDS was about 21 nm. 
Size and curcumin content in the SMEDDS showed no significant variation when stored 
for three months at 4 ˚C. In order to investigate the transport mechanism of curcumin in 
SMEDDS, the method of perfusion in rat intestine was used because it can give a reliable 
prediction of oral absorption of drug in humans (Zakeri-Milani, Valizadeh et al. 2007). 
Curcumin-loaded SMEDDS demonstrated concentration-independent absorption in the 
rat’s intestine, which might contribute to intestinal absorption of curcumin in SMEDDS 
via passive transfer by diffusion across the lipid membranes. 
Lin et al., (2009) also used a ternary phase diagram of a curcumin-encapsulated 
O/W microemulsion system. Specifically, their formulation used food-acceptable 
components lecithin and Tween 80 as the surfactants and ethyl oleate as the oil phase. A 
microemulsion was prepared when the weight ratio of aqueous phase (deionized water): 
surfactants (Tween 80 and lecithin): oil phase ranged from 10:5:1 to 10:1:0.3 at the fixed 
lecithin to Tween 80 molar ratio of 0.3. Homogeneous and yellow transparent curcumin 
encapsulated microemulsions were obtained using isopropyl myristate (IPM) and ethyl 
oleate (EO) as the oil phase. The composition of the curcumin microemulsion (DI water: 
surfactants (the mole ratio of lecithin/Tween 80 was 0.3): EO = 10:1.7:0.4 in wt ratio) 
was stable for 2 months with an average diameter of 71.8 ± 2.45 nm. Microemulsion 
formulations prepared from loading curcumin of different doses were tested for their 
permeation into BALB/c mouse skin. In the in vitro skin permeation study, both the 
dose–response and time-dependent studies of the encapsulated curcumin equations 
showed that MEC2 (30 mg of curcuminoids loaded into 10 mL of microemulsion 
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solution) was the most suitable formulation with reduced particle diameter and maximum 
permeation capability.  
Wang et al., (2008) produced and characterized O/W nanoemulsions consisting of 
medium chain triacylglycerols (MCT) as the oil phase and Tween 20 as the emulsifier. 
An amount of 1% curcumin was able to be loaded in MCT. The mixtures of MCT, Tween 
20, and water were mixed under magnetic stirring for 30 min at a ratio of 10/10/80 to 
fabricate O/W emulsions. Some emulsion premixes were subjected to high-speed 
homogenization for 10 min. Some high-speed homogenized emulsions were further 
homogenized by using a high-pressure homogenizer for 6 cycles. Mean droplet sizes 
ranged from 618.6-79.5 nm. The oral administration of 1% curcumin in Tween 20 water 
solution showed little or no inhibition effect of TPA-induced edema of mouse ear. On the 
contrary, it was found that curcumin O/W emulsions could significantly improve the 
inhibition effect of TPA-induced edema of mouse ear from 43% to 85% for curcumin 
emulsion with droplet size of 618.6 nm and 79.5 nm, respectively. The 1% curcumin 
O/W emulsions showed improved inhibition on the edema of mouse ear, and such anti-
inflammation activity was further enhanced when the emulsion droplet sizes were 
reduced to below 100 nm. 
Bisht et al., (2007) synthesized a polymeric nanoparticle encapsulated formulation 
of curcumin – nanocurcumin – utilizing the micellar aggregates of cross-linked and 
random copolymers of Nisopropylacrylamide (NIPAAM), with N-vinyl-2-pyrrolidone 
(VP) and poly(ethyleneglycol)monoacrylate (PEG-A). Curcumin loading in the 
polymeric nanoparticles was done by using a post-polymerization method. In this process 
of loading, the drug was dissolved after the co-polymer formation has taken place. The 
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physical entrapment of curcumin in NIPAAM/VP/PEG-A polymeric nanoparticles was 
carried out as follows: 100 mg of the lyophilized powder was dispersed in 10 ml distilled 
water and was stirred to re-constitute the micelles. Free curcumin was dissolved in 
chloroform (CHCl3; 10 mg/ml) and the drug solution in CHCl3 was added to the 
polymeric solution slowly with constant vortexing and mild sonication. Curcumin was 
directly loaded into the hydrophobic core of nanoparticles by physical entrapment. The 
drug-loaded nanoparticles were then lyophilized to dry powder for subsequent use. 
Characterization of the polymeric nanoparticles by dynamic laser light scattering and 
transmission electron microscopy confirmed a narrow size distribution in the 50 nm 
range. The nanoparticles were also characterized via 1H NMR and FT-IR studies. Cell 
viability (MTT) assays were performed using equivalent dosages of free curcumin and 
nanocurcumin in a panel of human pancreatic cancer cell lines. The assay was terminated 
at 72 hours, and colorimetric determination of cell viability performed. Four of six cell 
lines demonstrate response to nanocurcumin (defined as an IC50 in the 10–15 µM range) 
– BxPC3, ASPC-1, PL-11 and XPA-1, while two lines were curcumin resistant – PL-18 
and PK-9. Nanocurcumin inhibited NFκB function in pancreatic cancer cell lines and 
downregulated multiple pro-inflammatory cytokines. 
1.5 In Vitro Digestion 
 
 Digestion within humans is a complicated process because of the compounds 
involved in aiding the process and the different environments encountered by the ingested 
food. These environments include the mouth, stomach, and small intestine. Lipid-based 
oral delivery systems have been utilized as a strategy to enhance bioavailability of poorly 
water soluble, lipophilic drugs (Humberstone and Charman 1997). In vitro lipid digestion 
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models are used to find in vitro-in vivo correlations, which are a key element for drug 
development. A marked advantage of using in vitro models is the ability to stimulate 
gastric or intestinal fluids to assess their in vivo performance.  
Recently, there has been an effort to develop lipid-based formulations of poorly 
soluble compounds for oral administration. The use of in vitro lipolysis models can 
attempt to probe solubilization in the aqueous phase during the progress of enzymatic 
degradation of lipid-based formulations (Fatouros and Mullertz 2008). With this 
information, in vitro lipid digestion models can serve as a screening tool for formulating 
and optimizing lipid-based formulations of drugs. Figure 3 shows an example of a 
dynamic in vitro digestion model (Porter, Trevaskis et al. 2007): 
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Figure 3: Lipid digestion models for in vitro assessment of lipidic formulations. (A) 
The models are built around a temperature-controlled (37°C) vessel that contains 
digestion buffer, bile salt (BS), and phospholipid (PL) (to represent a model intestinal 
fluid) into which lipid-based formulations are introduced. Digestion is initiated by the 
addition of pancreatic lipase and co-lipase. The onset of lipid digestion results in the 
liberation of fatty acid (FA), which in turn causes a transient drop in pH. (B) The drop in 
pH is quantified by a pH electrode that is coupled to a pH-stat meter controller and 
autoburette, which together automatically titrate the liberated FA by the addition of an 
equimolar quantity of NaOH. This maintains the pH at a set point (thereby allowing the 
pH-sensitive process of digestion to continue) and facilitates indirect quantification of the 
extent of digestion (by quantification of the rate of NaOH addition and assumption of a 
stoichiometric reaction between FA and NaOH). 
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The digestion model used in my study incorporated bile, lipase, and calcium 
chloride, while having a starting condition similar to a fasted state. Digestion products of 
triglyceride lipids may enhance drug solubilization and dissolution by stimulating bile 
salt and phospholipid secretion into the GI lumen (Hernell, Staggers et al. 1990) and 
enhance the solubilization capacity of endogenous bile salts/phospholipid mixed micelles 
by intercalation into the micellar structure (Laher and Barrowman 1983; Vetter, Carey et 
al. 1985). Thus, the formed micellar structure is very important to lipolysis digestion 
models.  
An ideal outcome of the digestion model is for the lipase to effectively digest the 
triglycerides and have the free monoglycerides form micelles encapsulating the 
curcumin. First, the triglyceride is hydrolyzed to form a single fatty acid and diglyceride. 
Next, the diglyceride is hydrolyzed to produce a second fatty acid and a corresponding 2-
monoglyceride. The 2-monoglyceride may isomerize into 1-monoglyceride and be further 
hydrolyzed into a third fatty acid and glycerol, but this process is generally believed to be 
limited in vivo (Mattson and Volpenhein 1964).  
The progress of triglyceride lipolysis is generally monitored in vitro using an 
automated pH-stat titration apparatus (Alvarez and Stella 1989; MacGregor, Embleton et 
al. 1997). The limitation of this methodology is that it quantifies the rate and extent of 
digestion indirectly via titration of fatty acids produced. However, direct detection and 
quantification of lipolytic products such as triglycerides, diglycerides, monoglycerides, 
and fatty acids is difficult because of the lack of chromopohoric groups on these 
molecules (Sek, Porter et al. 2001). The accuracy of the pH-stat titration technique in 
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quantifying the fatty acid produced during lipid digestion is highly dependent on the 
ionization of fatty acid and the availability of titratable fatty acid (Sek, Porter et al. 2002).  
1.6 Caco-2 Cell Line 
 
 Recently, new insights about the mechanisms underlying intestinal transport of 
carotenoids have been provided by the use of human intestinal cell lines. Several attempts 
to obtain differentiated intestinal cell lines from normal tissues have not been successful, 
but established differential intestinal lines have been developed form human colon 
adenocarcinoma cells (Ranaldi, Bellovino et al. 2007). The majority of in vitro transport 
studies reported have used Caco-2 cells because these cells show, in vitro, most of the 
characteristics of enterocyte cells in the small intestine (Pinto, Robineleon et al. 1983). 
 Caco-2 cells have been extensively used to study intestinal transport of nutrients, 
drugs, and xenobiotics (Ranaldi, Islam et al. 1992; Ferruzza, Ranaldi et al. 1995; Shah, 
Jogani et al. 2006). The differentiative process of Caco-2 cells is a spontaneous event 
dependent on the time that cells are maintained in culture. It has been reported that 
differentiation occurs 2 – 3 weeks after initial confluency (Hidalgo, Raub et al. 1989; 
Chantret, Rodolosse et al. 1994; Lind, Jacobsen et al. 2007). Upon differentiation, cells 
give rise to a monolayer of polarized epithelial cells joined by a functional tight junction 
system and display several biochemical and functional characteristics typical of a mature 
enterocyte cell. Figure 4 depicts a differentiated Caco-2 cell (Ranaldi, Bellovino et al. 
2007): 
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Figure 4: Schematic representation of Caco-2 cell grown on filter. Monolayers on the 
apical side of the cell are easily accessible, making it an ideal model to study both 
absorption and excretion. 
 
For transport experiments, cells are plated in the Caco-2 culture system, which represents 
the intestinal mucosa environment in which the lumen is separated from the bloodstream 
by the intestinal epithelial monolayer. Trans-epithelial passage of molecules from the 
apical to the basolateral side of the monolayer can be easily measured in different 
experimental conditions, thus allowing to discriminate factors involved in transport 
mechanisms (Ranaldi, Bellovino et al. 2007). 
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CHAPTER 2 
 
FORMULATE AND CHARACTERIZE O/W NANOEMULSIONS USING 
DIFFERENT CHAIN LENGTH OILS WITH ENCAPSULATED CURCUMIN 
2.1 Introduction 
 
 Curcumin has attracted considerable attention in recent years due to its great 
variety of beneficial and biological and pharmacological activities (Duvoix, Blasius et al. 
2005). However, curcumin suffers from low bioavailability and is essentially insoluble in 
water at acidic or neutral pH (Maiti, Mukherjee et al. 2007). Many attempts have been 
made to improve water solubility and bioavailability of curcumin. Previous delivery 
systems have used complexation of curcumin with macromolecules including 
polysaccharides and phospholipids (Tonnesen, Masson et al. 2002; Liu, Lou et al. 2006). 
These delivery systems have the disadvantage of using non-food grade components and 
organic solvents.  
 Emulsion-based delivery systems are being increasingly used for encapsulating 
lipophilic bioactive components (Porter, Trevaskis et al. 2007). The curcumin can be 
solubilized in the oil, dispersed, phase and then homogenized with the water, continuous, 
phase. Nanoemulsions can be prepared using a dual high-speed and high-pressure 
homogenization technique to create droplet sizes in the 20 – 200 nm range (Solans, 
Izquierdo et al. 2005). 
 The objective of this chapter is to formulate and characterize curcumin-loaded 
O/W nanoemulsions. Specific conditions involving nanoemulsion stability are also noted. 
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2.2 Materials and Methods 
 
2.2.1 Materials 
 
Curcumin (~95.2% pure, from Curcuma longa) was purchased from Bepharm 
Ltd. (Shanghai, China) and used without further purification. Powdered BioPURE β-
Lactoglobulin (β-Lg; emulsifier) was provided by Davisco Foods International, Inc. (Le 
Sueur, MN). Corn oil (oil, LCT) was purchased from a local market and was used 
without further purification. Miglyol® 812 (oil; MCT) was purchased from SASOL 
(Houston, TX). Tributyrin (98%) (oil; SCT) was purchased from Sigma Aldrich (St. 
Louis, MO). Double deionized water was used in all experiments. A 5 mM pH 7 
phosphate buffer solution (PBS) was produced by dispersing 0.011% of anhydrous 
NaH2PO4 and 0.058% of anhydrous Na2HPO4. The chemicals for the phosphate buffer 
preparation were purchased from Sigma Aldrich and Fisher, respectively. 
2.2.2 Maximum Solubility of Curcumin 
 
The maximum solubility of curcumin in each oil phase that had been heated to 60 
˚C was determined. To ensure maximum curcumin dissolution, the heated oil phase 
containing excess curcumin was magnetically stirred for 10 min and then sonicated for 20 
min at 60 ˚C. The resulting solution was centrifuged (1750 rpm, Fisher Scientific 225A, 
Fisher) at room temperature for 10 min and the supernatant was saved. The supernatant 
was then diluted to an appropriate concentration to be analyzed by UV-VIS (wavelength 
dependent on oil type for emulsion, Ultrospec 3000 Pro, GE) with the pure oil used as the 
blank. 
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2.2.3 Curcumin Photostability 
 
Curcumin stability in oil was measured by UV-VIS spectroscopy. Curcumin-
loaded oil was incubated at 37 ˚C with shaking of 150 rpm for 48 hours. Aliquots were 
measured for absorbance at 1-12, 24, 36, and 48 hours. The oil without curcumin was 
used as a blank. 
2.2.4 O/W Nanoemulsion Preparation 
 
Curcumin-loaded O/W nanoemulsions were prepared. To maximize the curcumin 
dissolution into the oil phase, the oil and aqueous phases were prepared separately. The 
aqueous emulsifier solution containing 1 wt% protein was prepared by dispersing β-LG 
into PBS and stirring for at least two hours to ensure complete hydration. The oil phase 
was prepared by adding 0.15% curcumin by weight into the heated 60 ˚C oil. To ensure 
maximum curcumin dissolution, the heated oil phase was magnetically stirred for 10 min 
and sonicated for 20 min at 60 ˚C. O/W nanoemulsions were prepared by homogenizing 
10 wt% oil phase with 90 wt% aqueous emulsifier solution in a M133/1281 high-speed 
blender (Biospec Products, Inc., ESGC, Switzerland) for 2 min at room temperature, 
followed by five passes at 9000 psi (~620 bars) through a Microfluidics M-110Y 
Microfluidizer™ (MFIC Corporation, Newton, MA, USA) with a F20 Y 75 µm 
interaction chamber. After preparation, emulsions were stored at 4 ˚C. 
2.2.5 Emulsion Characterization 
 
The particle size distribution (PSD) of the O/W nanoemulsions was measured 
using dynamic light scattering (Zetasizer Nano-ZS, Malvern Instruments, Worcestershire, 
U.K.), with each individual measurement being the average of 12 runs. Results were 
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reported as the average size (Z-average) and width (polydispersity index-PDI). Emulsions 
were diluted prior to analysis using buffer solution (5mM phosphate, pH 7.0) to avoid the 
effects of multiple scattering.  
2.3 Results and Discussion 
 
2.3.1 Curcumin Solubility and Photostability in Oil 
 
From now on, LCT refers to long chain triglyceride (corn oil), MCT refers to 
medium chain triglyceride (Miglyol® 812), and SCT refers to short chain triglyceride 
(tributyrin). Before the nanoemulsion could be formulated, the maximum curcumin-
loading capacity in each oil phase was determined. The maximum solubility of curcumin 
in different oils at 60 ˚C is seen below: 
Oil Type Maximum Solubility of 
Curcumin 
(% by weight) 
LCT 0.30 ± 0.10 
 
MCT 0.79 ± 0.25 
 
LCT:SCT Mix 1.94 ± 0.44 
 
SCT 2.98 ± 0.18 
 
Table 1: Effect of oil chain-length on maximum solubility of curcumin. Each 
measurement has been correlated to a previously made standard curve of 0.08% curcumin 
in the oil phase. Results are reported as the average of three measurements on freshly 
prepared samples. 
 
As seen in Table 1, as oil chain length decreased the ability to solubilize curcumin 
increased. This phenomenon could be due to entropy of mixing, which states that entropy 
change is not from the intermingling of the particles, but rather the change in the 
available volume per particle (Huyskens and Haulaitpirson 1985). Since SCT’s are 
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smaller molecules than MCT and LCT’s, adding curcumin to a given area does not 
change the molecular configuration as it would for MCT and LCT’s. Another explanation 
is that, at a given mass of oil, there are more SCT molecules than higher chain length 
triglycerides because of the lower molecular weight. The amount of oxygen atoms on 
each triglyceride molecule are the same, regardless of fatty acid chain length. Thus, at a 
given mass, there are more available oxygen molecules to hydrogen bond to curcumin in 
SCT as compared to MCT and LCT. Interesting results were seen for the LCT:SCT mix 
because the average solubility was approximately halfway between the average solubility 
of only LCT and SCT. There was no synergistic or inhibitory effect seen with mixing the 
two oils. With these results, I selected 0.15% by weight curcumin in oil phase for my 
nanoemulsions so as to make sure that 100% solubilization of curcumin in the oil was 
possible in the experimental conditions.  
 A temperature of 60 ˚C was selected for initial dissolution because it was a 
temperature that could be replicated in industrial conditions and curcumin-loaded 
emulsions have been previously prepared with curcumin being dissolved into hot oil 
(Wang, Jiang et al. 2008). Subsequent use of the curcumin-loaded oil at temperatures 
ranging from 25 - 60 ˚C (doing dilutions, making emulsions, etc., would use oil whose 
temperature would fall to between 25 - 60 ˚C) showed that the curcumin stayed 
solubilized in the oil. Noticeable recrystallization of curcumin only occurred after 24 
hour storage in refrigeration (4 ˚C) for MCT and LCT. SCT and LCT:SCT mix showed 
no noticeable recrystallization in refrigeration after 24 hours. 
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Curcumin stability in oil was tested at 37 ˚C over a 48 hour time span to see if 
there was any decrease in absorbance, which correlated to curcumin falling out of oil. 
The results are seen in Figure 5: 
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Figure 5: Effect of storage time on curcumin stability in oil. Results are reported from 
one experiment on freshly prepared samples.  
 
Absorbance did not decrease an appreciable amount over a 48 hour time period. Thus, 
photo-stability was not heavily influenced when the curcumin was in oil. With these 
results, I hypothesized the curcumin that was incorporated into the emulsion stayed 
encapsulated in the oil phase during the duration of the emulsion’s use and its photo-
stability would not wane. Further experiments could be done to test this by dissolving 
aliquots of the emulsion in organic solvent (such as chloroform) and test the absorbance 
as a function of storage time. 
2.3.2 O/W Nanoemulsion Characterization 
 
Curcumin-containing O/W nanoemulsions were formulated using a 
microfluidizer. A general diagram of the microfluidizer is seen below with a targeted 
view of the interaction chamber (Lagoueyte and Paquin 1998; Vladisavljevic, Lambrich 
et al. 2004): 
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(A) Diagram of microfluidizer 
 
 
 
(B) Diagram of interaction (homogenizing valve) chamber  
 
Figure 6: Diagram of microfluidizer used for O/W nanoemulsion formulation. 
 
Figure 6 showed how nanoemulsions were produced with a high-pressure 
apparatus following initial homogenization by a high-speed blending process (pre-
emulsion). All nanoemulsions produced by microfluidization were 10% O/W (by weight) 
with 0.15% curcumin (by weight) in the oil phase. The particle size distributions (PSD) 
of the nanoemulsions are presented in Table 2 as the mean (Z-average) and width 
(polydispersity index-PDI):  
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Oil Type Z-average (nm) PDI (nm) 
LCT 181 ± 9 0.19 ± 0.02 
MCT 174 ± 2 0.16 ± 0 
LCT:SCT mix 182 ± 0 0.13 ± 0.01 
SCT 1981 ± 1061 0.75 ± 0.31 
Table 2: PSD of curcumin-loaded nanoemulsions. PSD analysis was performed by 
dynamic light scattering. Results shown are from the “Intensity (%)” parameter. Results 
are reported from two measurements on freshly prepared samples. 
 
Figure 7 shows graphical representations of results used to obtain values in Table 2: 
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(Figure 7 continued) 
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(D) SCT with curcumin (volume %) 
 
Figure 7: Particle size distribution (PSD) of 10% oil with 0.15% curcumin O/W 
emulsion. Results are reported as one sample used in PSD analysis. 
 
In Figure 7, for LCT (A, B) and SCT (C, D) with curcumin, PSD was shown using 
intensity and volume percentage as two parameters for how PSD data can be collected. 
These are two common representations used for PSD data and it is important to note the 
differences that result when selecting parameters to show PSD data. The Z-average and 
PDI data could change to a significant extent based on which parameter the data is being 
reported (as seen in the graphs). From now on, I will present PSD data using the 
“Intensity (%)” parameter.  
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The curcumin-containing O/W nanoemulsions were prepared using a dual high-
speed and high-pressure homogenization technique. Emulsions are considered 
nanoemulsions if they have a droplet size range between 20 – 200 nm. Microemulsion 
droplet sizes range from 1 – 20 nm and conventional emulsion droplet sizes range from 1 
– 100 µm (Solans, Izquierdo et al. 2005; Wooster, Golding et al. 2008).  
 As seen in Table 2, the homogenization technique used produced nanoemulsions 
in a limited droplet size range independent of oil type, except for SCT. In Figure 7, the 
PSD showed a system that was monomodal for LCT. Sometimes there was a slight peak 
at the 4 – 6 µm range, making the distribution bimodal. This could be due to aggregated 
emulsion droplets. These trends were also seen for MCT and LCT:SCT mix. However, 
the emulsions made with SCT showed droplet growth and/or aggregation, as seen by the 
multimodal PSD. Emulsions containing SCT in the lipid phase are highly unstable and 
have been prone to droplet growth. This is due to Ostwald ripening because of the 
relatively high water solubility of the low molecular weight triacylglycerol (Li, Le Maux 
et al. 2009).  
LCT and MCT nanoemulsions were kept in refrigeration for up to 10 days 
(duration of emulsion use) without any noticeable phase separation or curcumin fallout 
observed. LCT:SCT mix nanoemulsions were kept in refrigeration for up to 3 days 
(duration of emulsion use) without any noticeable phase separation or curcumin fallout 
observed. SCT nanoemulsions showed separation within hours and need to be made fresh 
everyday. As stated before, further experiments could be done to test the instability 
mechanism and determine the maximum storage life of these emulsions at 4 ºC.  
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2.4 Conclusions 
 
Curcumin-loaded O/W emulsions were prepared. For LCT, MCT, and LCT:SCT 
mix, these were considered nanoemulsions because their particle size was under 200 nm. 
SCT emulsions were not considered nanoemulsions because their size distribution was 
most closely linked to conventional emulsions. The theoretical maximum amount of 
curcumin able to be loaded at 60 ˚C was determined. As chain-length decreased, 
maximum curcumin solubility increased and this was most likely due to the entropy of 
mixing effect. With this knowledge, nanoemulsions with 0.15% curcumin were selected 
for further comparative studies involving the different chain-length oils. 
 Curcumin photo-stability in the pre-emulsion oil phase (up to 48 hours) was 
confirmed and it was hypothesized that the curcumin stayed encapsulated in the oil phase 
during the duration of the nanoemulsion’s use. Minimum storage time limits for 
nanoemulsions at 4 ˚C were identified and were oil dependent. Future work can be 
performed to determine the maximum storage limit of these nanoemulsions and see 
which mechanism, gravitational separation, curcumin fallout, or a combination of both, is 
responsible for the destabilization. 
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CHAPTER 3 
 
CHARACTERIZE THE DIGESTION OF CURCUMIN O/W NANOEMULSIONS 
USING AN IN VITRO DIGESTION MODEL 
3.1 Introduction 
 
 The use of lipid and surfactant-based formulations is one of several approaches 
that have been applied in order to improve the oral bioavailability of poorly aqueous 
soluble compounds intended for oral administration (Fatouros and Mullertz 2008). Lipids 
may enhance the absorption of poorly water-soluble, lipophilic drugs by their actions on 
gastric transit, intestinal permeability, and drug metabolism. However, lipids are most 
widely used to enhance drug solubilization and dissolution in the gastrointestinal tract 
(Constantinides 1995; Charman, Porter et al. 1997). 
 Gastrointestinal lipid digestion is a complex process and the impact of digestion 
on the drug-solubilization process needs to be elucidated. In vitro digestion models have 
recently gained much attention as a tool to understanding the digestion process. The use 
of an in vitro lipolysis model has been proposed as an approach to probe solubilization in 
the aqueous phase during the progress of enzyme degradation of lipid-based formulations 
(Zangenberg, Mullertz et al. 2001; Zangenberg, Mullertz et al. 2001; Pouton 2006) and 
for understanding the partitioning of the drug substance between the formed colloid 
phases during the digestion of lipids (Porter, Trevaskis et al. 2007). Ultimately, a 
successful in vitro digestion model will be able to predict in vitro-in vivo correlations 
because this is a prerequisite for rational development for drug delivery systems (Fricker, 
Kromp et al. 2010).  
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The objective of this chapter is to use an in vitro digestion model to characterize 
initial rate and extent of digestion of the previously formulated (nano)emulsions.  
3.2 Materials and Methods 
 
3.2.1 In Vitro Digestion Model 
 
The dynamic in vitro digestion model used was a modification of those described 
by Mun et al. and Zanenberg et al. (Zangenberg, Mullertz et al. 2001; Mun, Decker et al. 
2006). This model was meant to mimic the environment of the GI tract in a fasted state. 
The procedure was as follows: Emulsion and PBS (30.0 mL in total) was placed in a 
clean beaker in a water bath at 37.0 °C for 10 min and adjusted to pH 7 with NaOH 
solution (range from 0.05 – 1M). Then, 4.0 mL of bile extract solution containing 187.5 
mg of bile extract dissolved in PBS (pH 7.0) and 1.0 mL of CaCl2 solution containing 
110 mg of CaCl2 dissolved in PBS (pH 7.0) was added into the 30 mL emulsion under 
stirring. The resultant mixture was then adjusted to pH 7. Finally, 2.5 mL of freshly 
prepared pancreatin suspension containing 60 mg of lipase dissolved in phosphate buffer 
(pH 7.0) was added to the mixture. The bile solution and lipase solution concentrations 
were 5.0 mg/mL and 1.6 mg/mL respectively. At this point, the pH-stat was started. The 
pH-stat (Metrohm, USA Inc.) was used to monitor and control the pH (at pH 7) of the 
digestion solution. The volume of added NaOH solution (500 mM) reflected the amount 
of free fatty acids generated by lipolysis of the initial triacylglycerols. Experiments ran 
for 2 hours. 
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3.2.2 Post-Digestion Characterization 
 
After in vitro digestion, emulsions were centrifuged (12500 rpm, Sorvall RC 6C 
Plus, DuPont) at 25 ˚C for 30 min. Aliquots were taken from the supernatant and were 
either filtered using a 0.45 µm filter or left unfiltered. The PSD of the post-digested 
supernatant was measured using dynamic light scattering (Zetasizer Nano-ZS, Malvern 
Instruments, Worcestershire, U.K.), with each individual measurement being the average 
of 12 runs. The emulsions were diluted prior to analysis using buffer solution (5mM 
phosphate, pH 7.0) to avoid the effects of multiple scattering.  
3.3 Results and Discussion 
 
3.3.1 In Vitro Digestion Titration Profiles 
 
 Conditions mimicking the fasted state are used with the caveat that a higher 
calcium concentration (20 mmoles) was used. This was done to ensure that complete 
digestion could be achieved. At much lower calcium concentrations (5 mmoles), 
complete digestion was never able to be achieved. The dynamic in vitro digestion model 
used a pH-stat method that indirectly quantified digestion extent. I characterized and 
compared digestion for 1, 1.5, and 2% (nano)emulsions using the four different oils 
mentioned in Chapter 2.  
 Digestion extent was calculated from Equations 2 and 3: 
NaOHTheo  =        (2) 
 
 
% FFA Released  =   %100×
Theo
Exp
NaOH
NaOH
    (3) 
 
( )
( )
( )
( )




NaOHoil
oil
concMW
mass 10002
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Equation 2 gave the theoretical volume, in mL, of sodium hydroxide (NaOH) titrant 
needed to neutralize the free fatty acids released from the triacylglycerols and was 
referred to as “NaOHTheo”. The massoil was the mass of the oil phase in each titration run 
(300 g), MWoil was the molecular weight of the oil used, and concNaOH was the 
concentration of titrant used in the titration run (0.50M). I hypothesized that each 
triacylglycerol would release two free fatty acids from its structure from the sn-1 and sn-3 
positions upon digestion because pancreatic lipase has an affinity for primary ester bonds 
on the outer portion of the molecule (Carey, Small et al. 1983). Pancreatic lipase 
hydrolyzes primary ester bonds of tri- and diglycerides to generate 2-monoglycerides and 
fatty acids, which are adsorbed through the intestinal barrier in the form of mixed 
micelles with bile salts (Schmid and Verger 1998). Equation 3 gave indirect digestion 
extent, percent free fatty acids released (% FFA released), with NaOHExp being the 
experimental volume of NaOH titrated. Titration profiles were generated from 
experiments with the in vitro digestion model and measured digestion extent (% FFA 
released; Equation 3) as a function of time. The titration profiles for nanoemulsions are 
seen in Figure 8:  
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(Figure 8 continued) 
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Figure 8: Effect of droplet concentration on digestion extent for different oils. 
Prepared nanoemulsions containing 0.15% curcumin in LCT (A), MCT (B), LCT:SCT 
mix (C), and SCT (D) were titrated for two hours. Results with “*” were statistically 
different from 1% droplet concentration. Results are reported as the average of three 
measurements on freshly prepared samples. 
 
As can be seen in Figure 8, there were differences in the profiles depending on the oil 
type used in the nanoemulsion. One common outcome for all oils was an initial period 
during which the rate of FFA released was relatively fast (from 0 to 1200 s), followed by 
another period when the rate decreased appreciably.   
LCT (Fig. 8A) showed that digestion extent was dependent on droplet 
concentration because as droplet concentration increased, digestion extent decreased. The 
amount of FFA released increased rapidly with time almost immediately after digestion 
starts and then leveled off as the reaction continued. The reduction in the rate of lipolysis 
may be due to the saturation of phospholipid/bile salt mixed micelles with digestion 
products at the oil:water interface as digestion progressed. Long-chain lipids generate 
water-insoluble products, which can interfere with lipase activity at the interfacial layer. 
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The LCT within the droplets had not been fully digested because the slope was still 
increasing after 2 hours (7200 sec).  
MCT (Fig. 8B) showed a statistical correlation of digestion extent being 
dependent on droplet concentration because as droplet concentration increased, digestion 
extent decreased. Values for 1.5 and 2% were similar, but the difference between 1 and 
2% was statistically significant. An interesting note about the results for MCT was that 
each droplet concentration produced a digestion extent greater than 100%. This suggests 
that MCT could release >2 FFA’s because Equation 3 used a maximum of 2 FFA’s 
released in determining digestion extent. MCT has been previously shown to go through 
interesterification and release 2 FFA’s from the sn-1 and sn-3 position. The products of 
triacylglycerol hydrolysis by gastric and pancreatic colipase-dependent lipases are FFA’s 
released from the sn-1,3 positions and sn-2 monoacylglycerols. This may be important 
because approximately 70% of the fatty acids absorbed as sn-2 monoacylglycerols are 
conserved in the original position during re-esterification to triacylglycerols in the 
intestinal cells (Small 1991). The 2-monglyceride is then able to be absorbed through the 
intestinal epithelial barrier. Thus, the ability to release >2 FFA’s seems unlikely. An 
alternative explanation for MCT’s results was that digestion products evolved during the 
digestion process are via breakdown of phospholipids and/or proteins. This can cause a 
drop in pH and results in increased volume of titrant added to the reaction vessel. 
However, more work needs to be done to verify if the high digestion extent is due to the 
broken down components or some other cause. 
LCT:SCT mix (Fig. 8C) showed no statistical correlation that digestion extent 
was dependent on droplet concentration. The values for 1.5 and 2% were similar. This 
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trend was similar to MCT’s titration profile, which suggests that the lipase and/or bile 
concentrations used may be limiting factors for digestion. Of note is that the titration 
profile followed a similar slope and shape to tributyrin (Fig. 8D) in that digestion extent 
was almost wholly completed within 1 hour (3600 sec). 
SCT (Fig. 8D) showed a dissimilar trend to LCT in that as droplet concentration 
increased, digestion extent was similar. At all three droplet concentrations tested, the 
titration profile was similar in slope and position. The SCT within the droplets cannot be 
said to be fully digested, but the digestion had come to near completion because the 
digestion extent did not increase appreciably after approximately 1 hour (3600 sec). This 
suggests that lipase had equal access to the oil droplets at all three droplet concentrations 
and that the lipase and/or bile concentration would have a limiting effect on the ability to 
hydrolyze oil droplets. 
This in vitro digestion model was designed to simulate lipid digestion within the 
small intestine, where the majority of lipid digestion normally occurs, and is based on 
measurements of the amount of FFA released from lipids (usually triacylglycerols) after 
lipase addition at pH 7.  The pH-stat reaction vessel contained components (lipase, bile, 
calcium) of digestive fluids that interact with the nanoemulsions and influence digestion 
rate and extent. In reality, ingested lipid droplets have to pass through the mouth and 
stomach before they reach the small intestine (Mcclements, Decker et al. 2009; Singh, Ye 
et al. 2009).  Consequently, the physicochemical properties of the originally ingested 
lipid droplets may have been altered appreciably due to their interactions with other 
molecules in the mouth and stomach such as salts, acids, mucin, gastric lipase, and 
proteases. Gastric lipase initiates lipid digestion in the stomach, which results in the 
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partial digestion of triglyceride to diglyceride and fatty acid (Hamosh, Scanlon et al. 
1981; Abrams, Hamosh et al. 1988). Although gastric lipolysis is a minor contributor to 
overall lipid digestion, it has been suggested to be responsible for up to 25% of acyl chain 
hydrolysis (Carriere, Barrowman et al. 1993; Renou, Carriere et al. 2001). The potential 
changes to emulsion structure during digestion can be seen in Figure 9 (Singh, Ye et al. 
2009): 
 
Figure 9: Diagram of possible changes in emulsions as they pass through the 
gastrointestinal tract.   
 
These interactions were ignored in my study because I wished to focus on the 
physicochemical processes that occurred within the small intestine, where the majority of 
lipid digestion normally occurs.  
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Lipase is a surface-active protein that can compete for the oil-water interface with 
other surface-active components (Reis, Holmberg et al. 2008), such as the β-lactoglobulin 
initially coating the lipid droplets or the bile salts added to the reaction vessel. Two 
important factors which determine lipase actions are the affinity of the enzymes for the 
substrate droplets and the ability of the enzymes to hydrolyze the substrate lipid of the 
emulsion particle (Verger and Dehaas 1976). At low lipase concentrations, there may be 
insufficient lipase present to displace β-lactoglobulin from the oil-water interface. Thus, 
the enzyme cannot come into close contact with the lipid substrate within the lipid 
droplets. My model simulated the fasted state, so this could explain not achieving 100% 
digestion within the 2 hour timeframe. 
The emulsion surfactant, β-lactoglobulin was used, is important to digestion 
because it reduces the free energy and interfacial tension of the system by adsorbing at 
the interface. The main thermodynamic driving force is the removal of hydrophobic 
groups from the aqueous phase by displacing water molecules from the interface (Singh, 
Ye et al. 2009). β-lactoglobulin, a whey protein, can adsorb to the interface and undergo 
unfolding and rearrangement to form a compact, stabilizing adsorbed layer (Dalgleish 
1990). 
 Digestion is also dependent on the presence of bile salts because they can either 
inhibit or stimulate digestion based on certain environmental parameters. Bile has been 
shown to displace surface-active materials from the droplet interface, bind lipase to the 
interfacial layer, and accelerate lipid digestion (Gargouri, Julien et al. 1983; Ivanova, 
Panaiotov et al. 1990; Mun, Decker et al. 2005). In the absence of co-lipase, bile salts 
have been shown to inhibit the ability of pancreatic lipase to digest LCT and the 
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suggested mechanism of inhibition is bile-salt-mediated desorption of lipase from the oil-
water interface (Vandermeers, Vandermeerspiret et al. 1976). In the presence of co-
lipase, bile salts increase the initial rate of FFA release by most likely reducing emulsion 
droplet size, thereby increasing the surface area available for pancreatic lipase binding 
(Borgstro.B and Erlanson 1973). 
 Activity at the oil-water interface of emulsion droplets is a crucial factor in the 
digestion process. My in vitro digestion model incorporated bile, calcium, and lipase to 
reproduce conditions in the small intestine when a lipid-based food is consumed. With 
these various components, many conflicting activities may influence digestion. Calcium 
can activate lipase and removes FFA’s from the oil-water interface so lipase can attach. 
In this sense, it is similar to co-lipase in that can inhibit pancreatic lipase desorption from 
the oil-water interface by removing FFA’s and other digestion products. However, co-
lipase, as a small protein, maintains the ability to anchor the lipase to the oil-water 
interface via binding to the interface itself (Lowe 1997). Bile can change the surface of 
the interface, thus allowing lipase to attach and it also removes poorly water-soluble 
lipolytic products from the oil-water interface by solubilization (Carey, Small et al. 1983; 
MacGregor, Embleton et al. 1997).  In contrast, phospholipids have been shown to inhibit 
lipase activity at the interface (Larsson and Erlansonalbertsson 1986). Some theorize that 
phospholipids can mix with bile salt to form mixed micelles that may act as an alternate 
binding site for co-lipase during digestion. This leads to reduced interfacial co-lipase 
concentrations and diminished pancreatic lipase binding at the oil-water interface (Patton 
and Carey 1981).  
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The rate and extent of lipid digestion was clearly higher when MCT was used as 
the lipid phase than when LCT was used. It has been previously shown that lipolytic 
digestion rates were substantially higher on MCT as compared to LCT emulsions 
(Deckelbaum, Hamilton et al. 1990). This effect can be attributed to the fact that the 
medium chain FFA digestion products arising from MCT have a higher dispersibility in 
aqueous media than the long chain FFA digestion products arising from LCT. The 
medium chain FFA’s produced during digestion of MCT are able to migrate rapidly into 
the surrounding aqueous phase and therefore do not inhibit the lipase reaction at the oil-
water interface. The long chain fatty acids produced by LCT tend to accumulate at the 
oil-water interface and inhibit lipase activity until they are removed by being solubilized 
in mixed micelles or precipitated by calcium ions into calcium soaps. Nanoemulsions 
containing SCT can be digested quickly because tributyrin is water-soluble, which allows 
lipase to access to the oil-water interface easily. Also, the short-chain FFA digestion 
products can be solubilized or complexed with calcium away from the interface much 
easier than long-chain FFA digestion products because of their greater amphiphilic 
nature. 
3.3.2 Lipase Effect on Digestion Extent  
 
The proposed in vitro digestion model simulated digestion using a fasted state. 
Digestion components of the model included lipase, bile, and calcium. One would expect 
the rate of lipid digestion to increase as the lipase concentration increased because there 
would be more total enzyme present in the system to catalyze the conversion of 
triacylglycerols to free fatty acids (Reis, Holmberg et al. 2009).  In addition, the amount 
of lipase present at the oil-water interface, where the lipolysis reaction occurs, would 
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increase as the lipase concentration increased. Figure 10 showed experiments that had 
lipase concentration as a function of droplet concentration and also at 1.6 mg/mL: 
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Figure 10: Lipase effect on droplet concentration for LCT. Percentages without 
additional numbers have a lipase concentration of 1.6 mg/mL. Percentages with 
additional numbers have the additional number’s lipase concentration. Results with “*” 
were statistically different from samples with a lipase concentration of 1.6 mg/mL at the 
same droplet concentration. Results are reported as the average of at least two 
measurements on freshly prepared samples. 
 
As can be seen in Figure 10, increasing lipase concentration resulted in increased 
digestion extent for LCT. All other factors (bile = 5 mg/mL; calcium = 20 mmoles) were 
held constant as lipase concentration was increased as a function of droplet concentration. 
Titration profiles for 1% droplet concentration were not included because their lipase 
concentration always stayed at 1.6 mg/mL. At higher lipase concentrations the adsorption 
and displacement processes occur rapidly, so that digestion can begin almost immediately 
after the enzyme was added to the reaction vessel. MCT (not pictured) had a similar trend 
to LCT in that initial digestion rate and digestion extent were increased as lipase 
concentration increased, but the differences were not statistically significant. These 
results suggest that at a higher lipase concentration, as would be seen in the fed state, 
digestion extent would increase. Thus, more work would need to be done with conditions 
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mimicking the fed state. SCT and LCT:SCT mix did not have enough samples to warrant 
graphical representation. 
3.3.3 Effect of Oil Type on Digestion 
 
A comparison of oil types used for nanoemulsion digestion was needed to see 
similarities and/or differences in the titration profiles. Figure 11 shows the different oil 
types for 2% droplet concentration samples: 
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Figure 11: Effect of oil type on digestion at set droplet concentrations. All samples 
titrated with 5 mg/mL bile, 1.6 mg/mL lipase, and 20 mmoles calcium. Results with “*” 
were statistically different from LCT. Results are reported as the average of three 
measurements on freshly prepared samples. 
 
Results in Figure 11 for 2% samples were similar at 1 and 1.5% samples (not pictured). 
However, for 1 and 1.5% droplet concentration only MCT was statistically different from 
LCT. SCT and LCT:SCT mix had greater digestion extent, but not in a statistically 
significant manner. First, MCT produced the highest digestion extent at >100% digestion 
for each droplet concentration. This suggests that MCT can be hydrolyzed to produce >2 
FFA’s per triacylglycerol, or, more likely, assembled digestion products are formed from 
broken phospholipid and protein breakdown that resulted in a pH drop independent of the 
drop resulting from FFA release. Second, those nanoemulsions containing SCT in the 
droplet, either wholly or combined with LCT, had the fastest initial digestion rates. SCT, 
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a water-soluble oil, could also have a faster rate because the oil and digestion products 
were better solubilized in the continuous water phase. Lipase would have greater access 
to the oil-water interface because digestion products would not compete for the oil-water 
interface as greatly when all components are solubilized in the continuous phase. In all 
three droplet concentrations, LCT was digested to the least extent. This can be due to the 
released FFA’s and other digestion products not being able to be removed effectively 
from the oil-water interface, not being solubilized by the bile, or not being complexed 
with calcium ions into calcium soaps. It has been shown that long chain lipolytic products 
are limited to bile salt concentration and the solubilization capacity of the media, while 
medium chain lipolytic products were able to rapidly dissociate from the oil-water 
interface to form colloidal dispersions or precipitate as soaps (Sek, Porter et al. 2002). 
It is important to note the initial digestion rate, in addition to final digestion 
extent. The initial digestion rate of the different oil nanoemulsions is seen in Figure 12: 
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Figure 12: Effect of oil type on initial digestion rate. These curves are from the first 
800 seconds of Figure 11. Results with “*” were statistically different from LCT samples. 
 
A more comprehensive breakdown of FFA release can be seen in Table 3: 
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Oil Type 100% FFA 
Released 
(mmoles) 
Initial FFA 
Released 
(mmoles) 
Total FFA 
Released 
(mmoles) 
SCT 1.99 1.49 ± 0.03 1.85 ± 0.08 
MCT 1.15 0.65 ± 0.20 1.56 ± 0.11 
LCT:SCT Mix 1.34 1.06 ± 0.08 1.33 ± 0.10 
LCT 0.69 0.40 ± 0.02 0.63 ± 0.06 
(A) 1% Droplet Concentration 
 
Oil Type 100% FFA 
Released 
(mmoles) 
Initial FFA 
Released 
(mmoles) 
Total FFA 
Released 
(mmoles) 
SCT 2.98 2.26 ± 0.26 2.90 ± 0.44 
MCT 1.73 0.93 ± 0.14 2.08 ± 0.10 
LCT:SCT Mix 2.00 1.38 ± 0.01 1.82 ± .05 
LCT 1.03 0.52 ± 0.04 0.83 ± 0.10 
(B) 1.5% Droplet Concentration 
 
Oil Type 100% FFA 
Released 
(mmoles) 
Initial FFA 
Released 
(mmoles) 
Total FFA 
Released 
(mmoles) 
SCT 3.97 2.71 ± 0.11 3.64 ± 0.33 
MCT 2.31 1.13 ± 0.22 2.62 ± 0.13 
LCT:SCT Mix 2.67 1.70 ± 0.08 2.38 ± 0.07 
LCT 1.38 0.61 ± 0.05 1.83 ± 0.17 
(C) 2% Droplet Concentration 
 
Table 3: Effect of oil type on digestion rate and extent at set droplet concentrations 
(for microfluidized emulsions). 
 
As can be seen in Figure 12, those nanoemulsions containing SCT, wholly or mixed with 
LCT, released FFA’s at a much faster rate (in a statistically significant manner) than 
nanoemulsions containing only LCT or MCT. These results were similar at all three 
droplet concentrations. The interfacial layer of SCT emulsions would be accessed by 
lipase at a faster rate because of the oil’s high amphiphilic nature. LCT had the slowest 
digestion rate suggesting that released, insoluble long chain FFA’s interfere with the 
oil:water interface for a longer extent than other oils, which inhibits the ability of lipase 
to hydrolyze the triacylglycerols.  
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 In Table 3, column “100% FFA Released” is the theoretical amount of FFA’s that 
would be released (Equation 4) if 100% digestion was achieved. The “initial FFA 
released” column is the mmole value after 800 sec of titration time, while “total FFA 
released” is the mmole value after 7200 sec of titration time. The value of 800 sec was 
selected for calculating the initial digestion rate because the curve was still comparatively 
linear at that time point. Interesting results were seen for MCT because that oil was the 
only one whose initial FFA release was a value that was <50% of the total FFA released 
at each droplet concentration. This could be due to the type of MCT used, rather than an 
intrinsic property of MCT because medium chain lipolytic products have been previously 
shown to dissociate rapidly from the digestion interface to form colloidal dispersion or 
precipitated soaps as compared to LCT (Sek, Porter et al. 2002).  
After in vitro digestion, the PSD of the produced digestion products was 
determined. This was done because, in vivo, it is the colloidal structures formed during 
digestion that become the actual carriers of lipophilic curcumin in the aqueous phase. 
These results can be seen in Table 4: 
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Oil Type Z-average (nm)- 
Filtered 
PDI (nm)- 
Filtered 
Z-average 
(nm)- 
Unfiltered 
PDI (nm)- 
Unfiltered 
LCT 155 ± 19 0.16 ± 0.07 99 ± 14 0.26 ± 0.03 
MCT 95 ± 16 0.36 ± 0 161 ± 39 0.51 ± 0.08 
LCT:SCT Mix 42 ± 7 0.55 ± 0 --- --- 
SCT --- --- --- --- 
(A) 1% Droplet Concentration 
Oil Type Z-average (nm)- 
Filtered 
PDI (nm)- 
Filtered 
Z-average 
(nm)- 
Unfiltered 
PDI (nm)- 
Unfiltered 
LCT 81 ± 15 0.17 ± 0.01 113 ± 5 0.37 ± 0.18 
MCT 122 ± 18 0.22 ± 0.04 121 ± 13 0.20 ± 0.01 
LCT:SCT Mix 56 ± 33 0.34 ± 0.19 131 ± 19 0.26 ± 0.04 
SCT --- --- --- --- 
(B) 1.5% Droplet Concentration 
Oil Type Z-average (nm)- 
Filtered 
PDI (nm)- 
Filtered 
Z-average 
(nm)- 
Unfiltered 
PDI (nm)- 
Unfiltered 
LCT 88 ± 19 0.17 ± 0.01 161 ± 10 0.42 ± 0.09 
MCT 62 ± 39 0.21 ± 0.02 68 ± 1 0.30 ± 0.04 
LCT:SCT Mix 82 ± 19 0.28 ± 0.04 120 ± 13 0.29 ± 0 
SCT --- --- --- --- 
(C) 2% Droplet Concentration 
Table 4: Effect of filtering post-digested aqueous phase on PSD (for microfluidized 
emulsions). Results are reported as the average of at least two measurements on freshly 
prepared samples. 
 
Statistical analysis could not be performed on Table 4 because “n” values differed 
between 2 – 4 for filtered and unfiltered samples at the different oils. These differences 
were due to some samples not being categorized as “quality results” by the DLS 
computer program. Those samples were not recorded for use in Table 4 and new samples 
had to be prepared for analysis to make sure each sample (oil type; droplet concentration; 
filtered vs. unfiltered) had at least two values. As seen, LCT and LCT:SCT mix filtered 
samples showed a trend of particle size decreasing as droplet concentration increased. For 
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unfiltered samples, there was a trend between increasing droplet concentration and 
decreasing particle size for MCT and the opposite trend for LCT. I hypothesize that most 
of the digestion products were mixed bile salt micelles because the released FFA’s could 
self-assemble into these structures during digestion. These colloidal structures formed 
during lipid digestion prevent precipitation and enhance absorption of the drug. Other 
structures include vesicles and liposomes because these products have previously been 
shown to have a PSD in the 100 – 200 nm range (Olson, Hunt et al. 1979; Szoka, Olson 
et al. 1980). Of note is that products with only SCT did not consistently have a size in the 
low nm range. All attempts produced polydisperse readings that the instrument did not 
quantify as “quality results” by the computer program. Explanations given were: particle 
size was too high for proper measurement, sample was aggregating or sedimenting, 
and/or sample size was too low. Thus, they were omitted from Table 4. This observation 
could be due to SCT being prone to Ostwald ripening, which results in droplet instability 
and growth (Li, Le Maux et al. 2009). 
Some post-digested samples were filtered before measurement because there were 
larger digestion products present that distorted the measurement due to the polydispersity 
(case of all SCT samples). This was dependent on the samples themselves and the need 
for filtering could only be identified after an initial run on the Zetasizer. Even then, some 
filtered samples did not register as “quality results”. The products, due to their large µm 
size, could be larger vesicles and/or liposomes that caused the isolated aqueous phase to 
not be transparent. Only filtered and unfiltered samples that were considered “quality 
results” by the computer program were included in Table 4. These samples ranged form 
monomodal to trimodal distributions. As PDI increased, peak number increased, but there 
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was no definitive cut-off value seen for differentiating between monomodal, bimodal, 
and trimodal distributions. A general trend followed was that PDI values under 0.20 
frequently generated monomodal distributions, PDI values between 0.20 – 0.60 were 
either bimodal or trimodal, and PDI values above 0.60 resulted in polymodal distributions 
that did not fit “quality results” for the instrument. 
Attempts were made to obtain the zeta potential, surface charge distributions of 
particle droplets, of the post-digested aqueous phase. With surface active components 
such as bile, insights into how the charge distributions could be related to particle size or 
what factors affect digestion extent would be useful for modeling processes associated 
with digestion. However, no results were ever deemed “quality results” by the DLS 
computer program.  
3.4 Conclusions 
 
 Nanoemulsions were subject to in vitro digestion and their digestion profiles were 
examined. Nanoemulsions containing MCT showed >100% digestion. This suggested 
that that MCT can release >2 FFA’s per triglyceride or, more likely, additional digestion 
products were formed by breakdown of phospholipids and/or proteins, which caused a 
drop in pH not associated with FFA release. This caused additional titrant to be added 
during digestion. More studies are needed to characterize formed digestion products and 
examine their role during in vitro digestion. A useful method is HPTLC, which can 
differentiate between mono-, di-, and tri-glycerides. Previous work has used this method 
to determine relative distributions of lipid digestion products throughout the digestion 
process (Sek, Porter et al. 2001; Sek, Porter et al. 2002). 
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 When lipase was added as a droplet concentration dependent value to LCT and 
MCT, the digestion extent increased significantly. These results suggest the need for a 
study using the fed state. These could produce different titration profiles for LCT and 
MCT because more lipase, as well as more bile and calcium, is present in the fed state. 
This could also affect the bioavailability of curcumin after in vitro digestion because of 
the greater possibility of curcumin being encapsulated in mixed micelles and other 
digestion products after digestion. More studies need to be performed to see the effect of 
digestion parameters, fasted vs. fed state, affecting digestion rate, digestion extent, and 
bioavailability. 
 In a comparison study between oil types, corn oil was digested the least after 2 
hours and this suggested that the long chain FFA’s released cannot be effectively 
removed from the oil-water interface by the concentrations of bile and calcium present. 
Thus, lipase faced more interference at the oil-water interface. Another explanation is that 
the long chain FFA’s were not solubilized as quickly as short and medium chain FFA’s, 
which affected lipase access to the oil-water interface of the emulsions. 
 On the effect of oil type on post-digestion particle size, statistical analysis could 
not be used due to varying “n” values. Some trends showed a decrease in particle size as 
droplet concentration increased. SCT did not have any values for a post-digestion micelle 
size that was not too polydisperse for proper measurements. This implied that short chain 
FFA’s were unable to effectively self-assemble into mixed bile salt micelles after in vitro 
digestion. 
 51 
CHAPTER 4 
 
DETERMINE BIOACCESSIBILITY OF CURCUMIN AFTER IN VITRO 
DIGESTION 
4.1 Introduction 
 
The term bioavailability is defined as the fraction of an ingested component that 
eventually ends up in the systemic circulation (Versantvoort, Oomen et al. 2005).  The 
overall bioavailability (F) of poorly water-soluble lipophilic components depends on a 
number of physicochemical and physiological factors such as bioaccessibility, 
absorption, and metabolism. A more complete description of those processes was seen in 
Chapter 1.3. 
There is growing interest in understanding and controlling the digestibility of 
emulsified lipids as they pass through the human gastrointestinal (GI) tract (Porter and 
Charman 2001; Pafumi, Lairon et al. 2002; Porter, Trevaskis et al. 2007; Mcclements, 
Decker et al. 2009; Singh, Ye et al. 2009). This knowledge is being used by the 
pharmaceutical industry to rationally design emulsion-based delivery systems to carry 
biologically active agents to specific locations within the GI tract and release them at a 
controlled rate (Pouton 2006; Porter and Wasan 2008). These delivery systems have been 
proposed as a means of increasing the bioavailability of highly lipophilic nutraceuticals 
or as a means of delivering functional food ingredients to specific locations within the GI 
tract. 
Curcumin possesses low bioavailability, as only a small fraction of the 
administered dose reaches systemic circulation.  Curcumin is only slightly absorbed into 
the gastrointestinal tract due to its poor solubility in water (Tonnesen, Masson et al. 
 52 
2002). Curcumin also suffers from rapid degradation into several reduced products after 
oral dosing, which limits its bioavailability (Ireson, Orr et al. 2001). Emulsion-based 
delivery systems represent a promising avenue to increase bioavailability of curcumin 
because curcumin can be solubilized in the lipid phase before being homogenized with 
another liquid, usually water-based. 
The objective of this chapter was to determine the percent bioaccessibility of 
curcumin from O/W nanoemulsions that had been subject to in vitro digestion.  
4.2 Materials and Methods 
 
4.2.1 Determination of Percent Bioaccessibility 
 
After in vitro digestion, emulsions were centrifuged (12500 rpm, Sorvall RC 6C 
Plus, DuPont) at 25 ˚C for 30 min. Aliquots of 5 mL were taken from the aqueous phase, 
washed with 5 mL of chloroform, and centrifuged (1750 rpm, Fisher Scientific 225A, 
Fisher) at room temperature for 10 min. The bottom layer was collected, top layer was 
washed with 5 mL of chloroform, and centrifuged (1750 rpm) at room temperature for 10 
min. The bottom layer was added to the previously set aside bottom layer, lightly mixed, 
and analyzed by UV-VIS spectrophotometry (wavelength dependent on oil type used in 
emulsion, Ultrospec 3000 Pro, GE) with chloroform used as the blank. 
4.3 Results and Discussion 
 
4.3.1 Steps leading to Bioaccessibility Determination 
 
 Equations 4 and 5 were used for determining percent bioaccessibility (%BIO) of 
the isolated aqueous phase:  
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Equation 4 determined the theoretical maximum mass, in mg, of curcumin present in the 
entire aqueous phase after in vitro digestion (MassCurcFinal). The right side of the equation 
made up the dilutions that were done to get the final mass amount of curcumin 
theoretically present in the aqueous phase. The MassCurcInitial was the mass of curcumin 
initially solubilized in the oil, MassOilTotal was the total mass of oil containing solubilized 
curcumin, MassOilEmulsion was the mass of oil used to produce the 10% O/W nanoemulsion 
from the initial oil containing curcumin, MassEmulsion was the total mass of the generated 
nanoemulsion, MassEmulsionTitrator was the mass of the sample used in an experiment in the 
in vitro digestion model, VolumeTitrator was the initial volume of all components used in 
the in vitro digestion model (37.5 mL), and VolumeAliquot was the volume of the aliquot 
of post-digested solution taken out and used for further studies (35 mL). Equation 5 
determined the mass of curcumin present in the isolated aqueous phase (MassCurcAliquot), 
which was then calculated into %BIO.  
 The MassCurcAliquot, and subsequent %BIO, was determined from Figure 13: 
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Figure 13: Standard curve of total curcumin in aqueous phase. This is a composite of 
three standard curves of curcumin dissolved in chloroform and formatted to correlate 
UV-VIS absorption to mass of curcumin in the isolated aqueous phase. The equation is y 
= 1.9218x - 0.0023. The R2 value = 0.9926.   
 
The aqueous phase was isolated after centrifugation of the post-digested solution. Figure 
14 shows the separated layers and theoretical make-up of these layers:   
   
 
(A) LCT      (B) MCT 
     
 
 
 
 
 
 
 
 
 
 
(Continued on next page) 
Oil Layer  
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(Figure 14 continued) 
 
 
 
 
 
 
 
 
 
 
 
 
    (C) Theoretical Composition of Layers 
 
Figure 14: Super-speed centrifugation of post-digestion solution. At left is the post-
digested sample of LCT (A). At right is the post-digested sample of MCT (B). At bottom 
is the theoretical composition of post-digested solution after ultra-centrifugation (C), as 
taken from (Porter, Trevaskis et al. 2007).  
 
As suggested by Fig. 14C, the pellet at the bottom of the tube consisted of precipitated 
curcumin and calcium complexed with oil (calcium soaps). The lower liquid phase 
(overall middle phase) was the aqueous phase I isolated to determine %BIO of curcumin. 
It most likely consisted of mixed micelles with curcumin as well as larger digestion 
products, vesicles and/or liposomes, which caused the phase to look translucent instead of 
transparent. Based on DLS measurements, these other products could be liposomes or 
vesicles because these products have previously been shown to have a PSD in the 100 – 
200 nm range (Olson, Hunt et al. 1979; Szoka, Olson et al. 1980). It should be noted that 
the upper liquid (overall upper) phase was only seen for LCT (Fig. 14A). Previous work 
showed that LCT was not able to be digested fully, so the undigested oil that still 
contained curcumin could be seen at the top. The MCT sample (Fig. 14B) did not have an 
undigested oil layer, as its titration profile suggested complete digestion of the oil phase. 
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 It must be noted that the color of the aqueous phases for the four oil formulations 
was different. Thus, oil type affected the composition of micelles in the aqueous phase 
and may be related to each oil producing different extents of digestion. For example, the 
SCT aqueous phase was colored, but the %BIO was close to zero percent. Even though 
SCT was hydrolyzed to a large extent, there seemed to be little curcumin in micelles or 
other colloidal structures. LCT, on the other hand, had less digestion extent and an 
appreciable amount of curcumin was solubilized in micelles. These results suggested that 
colloidal structure compositions were dependent of fatty acid chain length. More work 
needs to be done to elucidate these findings. 
Figure 15 shows the emulsion at various stages of the experiment to illustrate how 
%BIO was calculated: 
 
Figure 15: Different stages of experiment to calculate %BIO (for microfluidized 
emulsions). Far left is the stock emulsion (1.5% MCT) with 0.15% curcumin, middle left 
is the post-digested solution after in vitro digestion, middle right is the isolated aqueous 
phase after super-speed centrifugation, and far right is the chloroform with curcumin 
measured by UV-VIS (bottom layer). 
 
The far right picture in Fig. 15 was the first wash of chloroform (5 mL) on the isolated 
aqueous phase (middle right of Fig. 15). The bottom layer was collected and a second 
wash of 5 mL of chloroform was done to obtain residual curcumin in the aqueous phase 
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that was not obtained from the first wash. Rough estimates (data not shown) showed that 
approximately 85 - 90% of the final amount of obtained curcumin was in the first wash, 
while the other approximate 10 - 15% was obtained in the second wash. It must be noted 
that these percentages relate to the amount of curcumin that was actually collected 
(%BIO) and not the total amount of curcumin that was in the system (MassCurcFinal). Thus, 
two washes of chloroform were necessary for getting an accurate assessment of curcumin 
present in the aqueous phase. An interesting difference between the centrifuged samples 
is seen in Figure 10: 
 
 
Figure 16: Post-centrifugation of first wash of 1.5% LCT with chloroform. 
 
The sample in Figure 16 was LCT and no other oil used produced the three layers seen 
when centrifuging after chloroform addition. The precipitate layer was found at all three 
droplet concentrations. Other oils produced a thin, delicate layer of precipitate between 
the bottom chloroform and upper aqueous layer. The bottom layer contained dissolved 
curcumin in chloroform, while the upper layer contained other solubilized digestion 
products. I hypothesized that the middle layer in LCT samples consisted of undigested oil 
and precipitated digestion products such as mono- and di-glycerides that did not form 
larger micellar structures. Further analysis is needed to determine the identity and ratio of 
Precipitate 
Layer  
 58 
contents within this precipitate layer. A useful method is HPTLC, which can differentiate 
between mono-, di-, and tri-glycerides. Previous work has used this method to determine 
relative distributions of lipid digestion products throughout the digestion process (Sek, 
Porter et al. 2001; Sek, Porter et al. 2002). 
4.3.2 Bioaccessibility Determination 
 
The %BIO of curcumin after in vitro digestion is seen in Table 5: 
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Droplet 
concentration 
(%) 
LCT 
(%) 
Lipid 
Digested 
(%) 
1 20 ± 10 92  ± 9 
1.5 40 ± 6* 80 ± 9 
2 41 ± 4* 68 ± 6 
(A) LCT 
 
Droplet 
concentration 
(%) 
MCT 
(%) 
Lipid 
Digested 
(%) 
1 8 ± 1 135 ± 9 
1.5 20 ± 7* 120 ± 6 
2 58 ± 6* 113 ± 6 
(B) MCT 
 
Droplet 
concentration 
(%) 
LCT & SCT 
mix 
(%) 
Lipid 
Digested 
(%) 
1 3 ± 1 99 ± 8 
1.5 9 ± 3* 91 ± 2 
2 20 ± 3* 89 ± 3 
(C) LCT:SCT Mix 
 
Droplet 
concentration 
(%) 
SCT 
(%) 
Lipid 
Digested 
(%) 
1 1 ± 0 93 ± 3 
1.5 1 ± 1 97 ± 15 
2 1 ± 1 92 ± 8 
(D) SCT 
 
Table 5: Effect of oil type on %BIO (for microfluidized emulsions). Results with “*” 
were statistically different from 1% samples. Results are reported as the average of three 
measurements on freshly prepared samples. 
 
As can be seen in Table 5 (A – C), LCT, MCT, and LCT:SCT mix all had increasing 
%BIO as droplet concentration increased. This suggests that increasing available oil for 
lipophilic compounds increases the likelihood of forming mixed phospholipid/bile salt 
micelles that incorporate curcumin during digestion. SCT (Table 4D) did not show the 
above trend. An explanation could be that short chain FFA’s are water soluble and cannot 
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be expected to interact with, or form, mixed bile salt micelles (Fatouros and Mullertz 
2008). This would result in digestion products that could not be considered mixed 
micelles, vesicles, and/or liposomes. They would be continually being aggregated or 
broken up. The PSD data results for SCT (Table 4) may be due to this phenomenon. 
During super-speed centrifugation, almost all free curcumin in solution would then be in 
the pellet phase with the calcium soaps and undigested tributyrin because free curcumin’s 
solubility in water is low. LCT:SCT mix (Table 4C) showed better results for 
bioaccessibility compared to SCT because LCT was incorporated. The long chain FFA’s 
would be better able to incorporate curcumin into stable mixed micelles or micellar 
structures because of the larger solubilization capacity of long chain FFA’s. 
 More work needs to be done to identify curcumin concentration in the two – three 
layers (dependent on oil type; Fig. 14C) immediately following super-speed 
centrifugation because then one would be able to see the distribution of curcumin within 
the sample. Initial attempts proved difficult because the top, undigested oil layer in LCT 
was also stuck to the sides of the centrifuge tube and totally isolating the pellet phase was 
not feasible because the solid would stick to the bottom and sides of the centrifuge tube.  
4.3.3 Theoretical Bioaccessibility Maximum 
 
MCT (Table 5B) had reached a maximum bioaccessibility of curcumin because 
the lipid has been fully digested, according to Equation 3. Comparing MCT to LCT 
(Table 5A) yielded interesting results because the bioaccessibility was higher for LCT at 
1 and 1.5% droplet concentration, but higher for MCT at 2%. Previous work has shown 
that, at low lipid concentrations, effective drug solubilization is possible with LCT, but 
the use of MCT can lead to drug precipitation (Porter, Kaukonen et al. 2004). However, a 
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further look was needed because not all of the LCT had been digested. If one assumes 
that the %BIO of curcumin is proportional to the amount of lipid digested, one can 
estimate the theoretical maximum %BIO of the system. Taking the average percent 
bioaccessibility of LCT currently and multiplying it by a factor that accounted for 
complete digestion results in Equation 6: 
i
iA D
BB
%
%100%% ×=         (6) 
 
Here, %BA is the adjusted %BIO, %Bi is the initial %BIO, and %Di is the initial percent 
lipid digested in the 2 hour timeframe (right hand column of Table 5A). MCT was not 
subject to this equation, i.e. average values did not change, because >100% lipid had been 
digested. Calculations are seen in Table 6: 
Droplet concentration 
(%) 
LCT 
(%) 
MCT 
(%) 
LCT + SCT mix 
(%) 
1 22 8 3 
1.5 50 20 10 
2 60 58 22 
 
Table 6: Theoretical %BIO if total digestion is achieved (for microfluidized 
emulsions). These do not take standard deviation into account, just average values. 
 
As can be seen in Table 6, there seemed to be a limit to the bioaccessibility of curcumin 
and it was independent of oil type (results for LCT and MCT). Titrations were run 
simulating fasted conditions, so there may not be enough bile, lipase, and/or calcium to 
increase the number of mixed micelles and other digestion products available that contain 
curcumin. Thus, more work needs to be done simulating fed conditions to see if an 
increase in available bile salts overcomes this apparent %BIO threshold of my system. 
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4.4 Conclusions 
 
 The %BIO of nanoemulsions subject to in vitro digestion was determined. For 
LCT, MCT, and LCT:SCT mix, an increase in droplet concentration resulted in an 
increase of %BIO. For SCT, there was low %BIO at each droplet concentration and this 
can be attributed to short chain FFA’s not being able to assemble into stable micellar 
structures during digestion. MCT produced the highest overall %BIO at 2% droplet 
concentration. Under fasted conditions, there theoretically appears to be a maximum of 
bioaccessibility at approximately 60%, as seen in Table 6. More studies need to be done 
that simulate fed conditions to see if more than approximately 60% of the curcumin is 
bioaccessible. Also, further analysis is needed to determine the identity and ratio of 
contents within the isolated aqueous phase after in vitro digestion. This information can 
then be used to predict lipid behavior during digestion and its effectiveness at creating 
carrier digestion products for curcumin. 
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CHAPTER 5 
 
COMPARE CURCUMIN ENCAPSULATED O/W NANOEMULSIONS TO 
CONVENTIONAL EMULSIONS 
5.1 Introduction 
 
 Curcumin is a highly lipophilic, poorly water-soluble bioactive component. 
Emulsion-based delivery systems have been proposed as a means of increasing the 
bioavailability of highly lipophilic nutraceuticals or as a means of delivering functional 
food ingredients to specific locations within the GI. To investigate their potential 
benefits, the emulsion-based delivery systems should be compared to other delivery 
systems of curcumin. 
 Previous studies have compared curcumin-encapsulated delivery systems to free 
curcumin in water in order to show potential benefits of the proposed curcumin-
encapsulated delivery system (Bisht, Feldmann et al. 2007; Wang, Jiang et al. 2008; 
Mukerjee and Vishwanatha 2009; Yu and Huang 2010). However, the maximum 
solubility of curcumin in water is 11 ng/mL (Tonnesen, Masson et al. 2002). Also, there 
is no surfactant in the system, so free curcumin in water is not a comparable delivery 
system to use. 
A more appropriate delivery system for comparison is a conventional emulsion 
because lipophilic curcumin can be solubilized greater in the dispersed oil phase and the 
presence of surfactant allows the dispersed phase to be maintained in the continuous 
water phase. Main differences between conventional emulsions and nanoemulsions 
include droplet size and creaming stability. Nanoemulsions have been produced with 
droplet sizes from 50-200 nm and conventional emulsions have a size range from 1-100 
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µm. Nanoemulsions possess high kinetic stability due to their extremely small emulsion 
droplet sizes in the range of 50-200 nm (Sonneville-Aubrun, Simonnet et al. 2004; 
Solans, Izquierdo et al. 2005). The small droplet size of nanoemulsions makes them 
resistant to physical destabilization via gravitational separation, flocculation and/or 
coalescence due to effective steric stabilization (Capek 2004; Tadros, Vandamme et al. 
2004; Solans, Izquierdo et al. 2005). Nanoemulsions, by increasing the solubility of a 
hydrophobic compound like curcumin, can enhance the compound’s absorption in the 
gastrointestinal tract (Patel and Sawant 2007).  
The objective of this chapter is to compare nanoemulsions to conventional 
emulsions in the parameters of digestion rate, digestion extent, PSD of aqueous phase, 
and %BIO to see if one delivery system was superior to the other. 
5.2 Materials and Methods 
 
5.2.1 Formulation and Characterization of Conventional Emulsions 
 
Curcumin-loaded O/W conventional emulsions were prepared in a similar fashion 
to the O/W nanoemulsions, except that they were not subject to the high-pressure 
homogenization technique after initial blending.   
The O/W conventional emulsions were measured using static light scattering 
(SLS) (Mastersizer S, Malvern Instruments, Worcestershire, U.K.). The volume moment 
mean (D4,3) and surface area moment mean (D3,2) were obtained. The emulsions were 
diluted prior to analysis using buffer solution (5mM phosphate, pH 7.0) as per instrument 
specifications.  
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5.2.2 In Vitro Digestion of Conventional Emulsions 
 
The O/W conventional emulsions were subject to the in vitro digestion model and 
the post-digested solution was analyzed by UV-VIS spectrophotometry for %BIO as 
prescribed in the methods for Chapters 3 and 4. 
5.3 Results and Discussion 
 
5.3.1 Conventional Emulsion Characterization 
 
 The droplet sizes for the conventional emulsions are shown in Table 7:  
Oil Type Volume Moment Mean 
(µm) 
Surface Area Moment 
Mean (µm) 
LCT 20 ± 11 4 ± 2 
MCT 22 ± 6 13 ± 4 
LCT:SCT Mix 19 ± 5 10 ± 6 
SCT 14 ± 2 12 ± 2 
Table 7: Conventional emulsion SLS mean values. Results are reported as the average 
of three measurements on freshly prepared samples. 
 
Graphical representations of results used to produce values in Table 7 are shown in 
Figure 17: 
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Figure 17: SLS graph of 0.15% curcumin conventional emulsion. 
 
The droplet sizes for the conventional emulsions were in the µm range, while droplet 
sizes for the nanoemulsions were in the nm range. This was a result of nanoemulsions 
being subject to a dual high-speed and high-pressure homogenization technique, while 
conventional emulsions were subject only to high-speed homogenization. Two means 
were presented because the volume moment mean (De Brouckere Mean Diameter) 
represented the size distribution of the droplet population, while the surface area moment 
mean (Sauter Mean Diameter) represented the mean diameter of the particles. In 
literature, these are two common means to present. These means are similar to moments 
of inertia and indicate the central point of the frequency around which the surface area or 
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volume/mass distribution would rotate. In effect, they are centers of gravity of the 
respective distributions (Berchane, Carson et al. 2007). A large standard deviation of the 
volume and surface area moment means would signify a larger distribution of particles at 
differing sizes.  
 As seen in Table 7, the trend between values for volume moment and surface area 
moment mean were only similar for SCT. This suggested that the blending 
homogenization process produced many particles with a mean diameter of approximately 
12 µm and a relatively small peak width (Fig. 17A). The disparate relationship between 
values for the other oils (much smaller surface area moment means than volume moment 
means) suggested that while the majority of particles were smaller than the volume 
moment mean, there were also particles with larger sizes than the volume moment means 
or the width of the peak(s) would be sizeable as compared to the average size value (Fig. 
17B). Thus, blending homogenization would not have been an appropriate 
homogenization process if a small distribution of evenly sized particles was wanted.  
5.3.2 Conventional vs. Nanoemulsion-Digestion 
 
It would be prudent to note differences in titration profiles between the two types 
of emulsions to see if digestion extent is proportional to initial droplet size. Titration 
profiles for the conventional emulsions and their comparisons to the nanoemulsions are 
seen in Figure 12: 
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(B) Conventional Emulsion vs. Nanoemulsion-MCT 
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(C) Conventional Emulsion vs. Nanoemulsion-SCT 
 
Figure 18: Effect of emulsion preparation method on digestion extent. The top graph 
is that of the conventional emulsion, while the middle and bottom graphs are both the 
conventional and nanoemulsion. For 18B and 18C, droplet concentrations with “-N” are 
those made by microfluidization (nanoemulsion) and those with “-C” are made via 
blending only (conventional). Results with “*” were statistically different from the 1% 
sample in 18A and corresponding nanoemulsion in 18C. Results are reported as the 
average of three measurements on freshly prepared samples. 
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For MCT (Fig. 18A), digestion at 2% droplet concentration of the conventional emulsion 
was significantly greater than 1% digestion. This difference was also seen in LCT (not 
shown). For MCT (Fig. 18B), digestion extent for conventional emulsions was greater 
than the nanoemulsion, but not in a statistically significant manner. For SCT (Fig. 18C), 
digestion at 1% droplet concentration of the conventional emulsion was significantly 
greater than the nanoemulsion. For LCT:SCT mix (not shown), digestion at 2% droplet 
concentration of the conventional emulsion was significantly greater than the 
nanoemulsion. No results were seen that had significantly greater digestion with 
nanoemulsions as compared to conventional emulsions. 
These results were interesting because the nanoemulsions’ smaller droplet sizes 
have a higher surface area to volume ratio and lipase would then have greater access to 
the oil:water interface for the nanoemulsions. Also, with smaller particle size, 
nanoemulsions would have a higher kinetic activity that would allow the oil:water 
interfaces to be less prone to being shielded by released FFA’s. Thus, digestion extent 
should be more complete for the nanoemulsions as compared to conventional emulsions. 
However, this was not seen. An alternative explanation is that pancreatic lipase would 
have the same affinity for the conventional emulsion droplets because, component-wise, 
they were the same as nanoemulsions. Thus, differences in digestion extent would be 
minimal. Previous work has suggested that product performance is poorly related to 
initial particle size of a dispersed formulation and instead is correlated more with the 
patterns of solubilization obtained after dispersion and digestion of the formulation in 
simulated intestinal fluid (Porter, Kaukonen et al. 2004; Sek, Boyd et al. 2006). 
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It is important to note the initial digestion rate, in addition to final digestion 
extent. The initial digestion rate of the different oil conventional emulsions is seen in 
Figure 19: 
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Figure 19: Effect of emulsion preparation method on digestion rate at 1% droplet 
concentration. For 19B, droplet concentrations with “-N” are those made by 
microfluidization (nanoemulsion) and those with “-C” are made via blending only 
(conventional). Results with “*” were statistically different from LCT (Fig. 19A) and 
corresponding nanoemulsion (Fig. 19B). Results are reported as the average of three 
measurements on freshly prepared samples. 
 
As seen in Figure 19, initial digestion rates of the conventional emulsions mirrored those 
of the nanoemulsions (Fig. 12) in that emulsions containing SCT, either wholly or mixed 
with LCT, had a significantly higher initial digestion rate than emulsions containing only 
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LCT or MCT. The lower graph in Figure 19 compared titration profiles of nanoemulsions 
(Fig. 8) to conventional emulsions. In all three droplet concentrations, conventional 
emulsions initially digested at a faster rate than nanoemulsions for every different oil 
type. However, statistical significance was only achieved for SCT at 1%, MCT at 2%, 
and LCT:SCT mix at 2% droplet concentrations. One explanation is that nanoemulsions, 
being of such a small size and having a higher kinetic activity than conventional 
emulsions, are more dispersed throughout the titration sample. Conventional emulsions 
are more prone to gravitational separation than nanoemulsions because the 
homogenization technique used to create conventional emulsions is not as rigorous. 
Within a short period of time, the oil phase can partially separate from the water phase 
and collect near the top of the reaction vessel. Also, conventional emulsions were 
prepared by blending in a vessel where the oil phase was wholly on top of the water 
phase before blending. Some of the oil droplets may have stayed towards the top of the 
reaction vessel and not be as dispersed in the continuous phase due to blending 
limitations of the handheld homogenizer. In contrast, nanoemulsions prepared with a 
microfluidizer were more completely mixed because the initially blended oil and water 
phase traveled a path through a series of small tubes where homogenization occurred. 
Upon addition of lipase, to the top of the reaction vessel, more conventional emulsion 
droplets may be hydrolyzed as opposed to the nanoemulsions dispersed throughout the 
sample. However, this seems unlikely as the reaction vessel had a stirrer to keep the 
solution in motion, which would not have been a deterrent to lipase being able to access 
emulsion droplets of conventional or nanoemulsions. A difference in titrant concentration 
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(0.50M NaOH) also seems unlikely because titrant solution was made every few weeks 
and showed no precipitation during use. 
A more comprehensive breakdown of FFA release of conventional emulsions can 
be seen in Table 8: 
Oil Type 100% FFA 
Released 
(mmoles) 
Initial FFA 
Released 
(mmoles) 
Total FFA 
Released 
(mmoles) 
SCT 1.99 1.79 ± 0.07 2.18 ± 0.12 
MCT 1.15 0.83 ± 0.23 1.60 ± 0.11 
LCT:SCT Mix 1.34 1.18 ± 0.12 1.39 ± 0.05 
LCT 0.69 0.42 ± .04 0.68 ± 0.11 
(A) 1% Droplet Concentration 
 
Oil Type 100% FFA 
Released 
(mmoles) 
Initial FFA 
Released 
(mmoles) 
Total FFA 
Released 
(mmoles) 
SCT 2.98 2.50 ± 0.02 3.26 ± 0.09 
MCT 1.73 1.39 ± 0.15 2.28 ± 0.22 
LCT:SCT Mix 2.00 1.69 ± 0.12 2.07 ± 0.10 
LCT 1.03 0.55 ± 0.06 0.90 ± 0.08 
(B) 1.5% Droplet Concentration 
 
Oil Type 100% FFA 
Released 
(mmoles) 
Initial FFA 
Released 
(mmoles) 
Total FFA 
Released 
(mmoles) 
SCT 3.97 3.04 ± 0.02 4.24 ± 0.15 
MCT 2.31 1.73 ± 0.34 2.85 ± 0.19 
LCT:SCT Mix 2.67 2.07 ± 0.13 2.75 ± 0.10 
LCT 1.38 0.67 ± 0.09 1.00 ± 0.14 
(C) 2% Droplet Concentration 
 
Table 8: Effect of oil type on digestion rate and extent at set droplet concentration 
for conventional emulsions. 
 
In Table 8, column “100% FFA Released” is the theoretical amount of FFA’s that would 
be released (Equation 3) if 100% digestion was achieved. The “initial FFA released” 
column is the mmole value after 800 sec of titration time, while “total FFA released” is 
the mmole value after 7200 sec of titration time. The value of 800 sec was selected for 
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calculating the initial digestion rate because the curve was still comparatively linear at 
that time point. For all oils at each tested droplet concentration, at least 50% of digestion 
was achieved during the first 800 sec. These results were similar to microfluidized 
emulsions (Table 3). 
5.3.3 Conventional vs. Nanoemulsion-Bioaccessibility 
 
The %BIO of curcumin after in vitro digestion is seen in Table 9: 
Droplet concentration 
(%) 
LCT 
(%) 
Lipid Digested 
(%) 
1 38 ± 22 98 ± 16 
1.5 56 ± 9 88 ± 8 
2 50 ± 10 73 ± 10 
(A) LCT 
 
Droplet concentration 
(%) 
MCT 
(%) 
Lipid Digested 
(%) 
1 3 ± 0 139 ± 9 
1.5 17 ± 6 132 ± 13 
2 59 ± 5* 123 ± 8 
(B) MCT 
 
Droplet concentration 
(%) 
Corn Oil and Tributyrin 
(LCT & SCT) 
(%) 
Lipid Digested 
(%) 
1 5 ± 3 104 ± 4 
1.5 20 ± 6* 103 ± 5 
2 45 ± 7* 103 ± 4 
(C) LCT:SCT mix 
 
Droplet concentration 
(%) 
SCT 
(%) 
Lipid Digested 
(%) 
1 0 ± 0 110 ± 6 
1.5 0 ± 0 110 ± 3 
2 0 ± 0 107 ± 4 
(D) SCT 
 
Table 9: Effect of oil type on %BIO for conventional emulsions. Results with “*” 
were statistically different from 1% samples. Results are reported as the average of three 
measurements on freshly prepared samples. 
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For MCT and LCT:SCT mix, an increase in droplet concentration corresponded to an 
significant increase in %BIO. For LCT, the 1.5% droplet concentration produced the 
highest %BIO, but the 2% droplet concentration value was similar. However, it must be 
noted that digestion extent for LCT decreased as droplet concentration increased, which 
would explain the similar %BIO values for LCT. If one assumes that the %BIO of 
curcumin is proportional to the amount of lipid digested, one can estimate the theoretical 
maximum %BIO of the system. If Equation 6 was applied to the LCT results to account 
for 100% digestion, those results are seen in Table 10: 
Droplet concentration 
(%) 
MCT 
(%) 
LCT 
(%) 
LCT + SCT mix 
(%) 
1 3 39 5 
1.5 17 64 20 
2 59 68 45 
Table 10: Theoretical %BIO if total digestion is achieved. These do not take standard 
deviation into account, just average values. 
 
As seen in Table 10, there was a maximum theoretical %BIO of LCT at 68%. For the 
nanoemulsions (Table 6), there was a maximum value of 60%. Titrations were run 
simulating fasted conditions, so there may not be enough bile, lipase, and/or calcium to 
increase the number of carrier digestion products containing curcumin.  With these 
conditions there could be a maximum amount of mixed bile salt micelles that could form, 
thus, limiting the amount of curcumin solubilized in the aqueous phase. Thus, more work 
needs to be done simulating fed conditions to see if there is a higher %BIO attainable. 
The results for Table 9 need to be compared to those of the nanoemulsions (Table 
5) to see which emulsion produced a greater percent bioaccessibility. The percent 
bioaccessibility of the conventional vs. nanoemulsions is seen in Table 11: 
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Droplet concentration 
(%) 
Nanoemulsion 
(%) 
Conventional Emulsion 
(%) 
1 20 ± 10 38 ± 22 
1.5 40 ± 6 56 ± 9 
2 41 ± 4 50 ± 10 
(A) LCT 
 
Droplet concentration 
(%) 
Nanoemulsion 
(%) 
Conventional Emulsion 
(%) 
1 8 ± 1* 3 ± 0 
1.5 20 ± 7 17 ± 6 
2 58 ± 6 59 ± 5 
(B) MCT 
 
Droplet concentration 
(%) 
Nanoemulsion 
(%) 
Conventional Emulsion 
(%) 
1 3 ± 1 5 ± 3 
1.5 9 ± 3 20 ± 6* 
2 20 ± 3 45 ± 7* 
(C) LCT:SCT mix 
 
Droplet concentration 
(%) 
Nanoemulsion 
(%) 
Conventional Emulsion 
(%) 
1 1 ± 0 0 ± 0 
1.5 1 ± 1 0 ± 0 
2 1± 1 0 ± 0 
(D) SCT 
 
Table 11: Effect of emulsion preparation method on %BIO at set droplet 
concentrations. Results with “*” were statistically different from their corresponding 
emulsion preparation at set droplet concentration. Results are reported as the average of 
three measurements on freshly prepared samples. 
 
With statistical significance, LCT:SCT mix showed greater %BIO for the conventional 
emulsion at droplet concentrations of 1.5 and 2%. MCT showed significantly greater 
%BIO for the nanoemulsion at 1%. For SCT, all three droplet concentrations were 
similarly low and suggest that short chain FFA’s cannot self-assemble into stable 
micelles. 
 These results implied that nanoemulsions were not significantly better delivery 
systems for curcumin than conventional emulsions. However, emulsion stability is an 
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issue that favors the use of nanoemulsions. Conventional emulsions creamed within 
hours, while nanoemulsions were much more stable to creaming. Conventional emulsions 
needed to be made fresh everyday. The stability difference is seen in Figure 20: 
 
Figure 20: Stability difference between nanoemulsions vs. conventional emulsions. 
At left is a conventional emulsion after 4 hours. At right is a nanoemulsion after 4 hours. 
 
LCT and MCT nanoemulsions were kept in refrigeration for up to 10 days 
(duration of emulsion use) without any noticeable phase separation or curcumin fallout 
observed. LCT:SCT mix nanoemulsions were kept in refrigeration for up to 3 days 
(duration of emulsion use) without any noticeable phase separation or curcumin fallout 
observed. SCT nanoemulsions showed separation within hours and need to be made fresh 
everyday. As stated before, further experiments could be done to test the instability 
mechanism and determine the maximum storage life of these emulsions at 4 ºC.  
5.4 Conclusions 
 
As compared to conventional emulsions, nanoemulsions were not significantly better 
delivery systems for curcumin. However, nanoemulsions are more stable than 
conventional emulsions in storage and may present a better alternative in industry to 
improve curcumin bioaccessibility and eventual bioavailability. 
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CHAPTER 6 
ONGOING WORK 
6.1 Introduction 
 
 As seen in my results, there seemed to be a maximum theoretical %BIO of 
approximately 60% for nanoemulsions and 68% for conventional emulsions. This could 
be due to starting conditions that mimicked the fasted state instead of the fed state. Thus, 
more work needs to be done with conditions resembling the fed state as a means of 
comparison to my previous work. 
 My previous work with emulsions shows, often, an increase in droplet 
concentration correlating to an increase in %BIO of curcumin. However, some may argue 
that a different approach is required to investigate %BIO because the amount (mass) of 
curcumin in each droplet concentration was not the same. My previous stock emulsions 
used for titration samples were 10% O/W, so diluting to a sample at 2% droplet 
concentration would have twice as much curcumin as a 1% sample. Thus, new 
experiments have been performed that keep the amount of curcumin the same and the 
additional droplet concentration is supplemented by an O/W emulsion of the same oil 
without curcumin. 
By its definition in Equation 1, bioavailability is comprised of bioaccessibility, 
metabolism, and absorption. My work has shown the bioaccessibility of curcumin in 
emulsions that are subject to in vitro digestion. To be able to effectively predict eventual 
bioavailability, a common tool used is the Caco-2 cell line. Caco-2 cell models have been 
used for predicting eventual bioavailability because mature, differentiated cells have the 
same characteristics as enterocyte cells in the small intestine. Uptake experiments with 
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Caco-2 cells are commonly used for determining eventual concentration of lipophilic 
drugs.  
6.2 Materials and Methods 
 
6.2.1 Fed State Conditions 
 
To simulate the fed state, a similar procedure to the in vitro digestion model of 
Chapter 3 was used with different concentrations of bile and lipase. In the simulated fed 
state, 4.0 mL of bile extract solution containing 750 mg of bile extract dissolved in PBS 
(pH 7.0) and 1.0 mL of CaCl2 solution containing 110 mg of CaCl2 dissolved in PBS (pH 
7.0) was added into the 30 mL emulsion under stirring. The resultant mixture was then 
adjusted to pH 7. Finally, 2.5 mL of freshly prepared pancreatin suspension containing 90 
mg of lipase dissolved in phosphate buffer (pH 7.0) was added to the mixture. The bile 
solution and lipase solution concentrations were 20 mg/mL and 2.4 mg/mL respectively. 
At this point, the pH-stat was started. The pH-stat (Metrohm, USA Inc.) was used to 
monitor and control the pH (at pH 7) of the digestion solution. The volume of added 
NaOH solution (0.50M) reflected the amount of free fatty acids generated by lipolysis of 
the initial triacylglycerols. Experiments ran for 2 hours. 
6.2.2 Alternative Method to Determine Bioaccessibility 
 
 The different approach to determining %BIO of curcumin was only slightly 
different than my procedure outlined in Chapter 4. Emulsions were created by the Sonic 
Dismembrator 500 (Fisher Scientific) by pulsing for 12 min and amplitude of 70%. The 
pulse rate alternated between on and off every 0.5 sec. For the in vitro digestion model, 
curcumin-containing stock emulsion (10% O/W) was added up to 1%. For samples at 1.5 
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and 2%, the remaining lipid was supplemented with diluted 10% O/W emulsion without 
curcumin diluted to the extra droplet concentration. After in vitro digestion, the method 
described in Chapter 4 was used to determine %BIO. 
Aliquots were taken from the supernatant and were left unfiltered. The mean 
particle size (z-average) and width (PDI) of the post-digested aqueous phase was 
measured using dynamic light scattering (Zetasizer Nano-ZS, Malvern Instruments, 
Worcestershire, U.K.), with each individual measurement being the average of 12 runs. 
The emulsions were diluted prior to analysis using buffer solution (5mM phosphate, pH 
7.0) to avoid the effects of multiple scattering. 
6.2.3 Caco-2 Cell Culture 
 
 The human colon adenocarcinoma cell line Caco-2 was obtained from American 
Type Cell Collection (ATCC, Manassas, VA, USA). They were cultured in Dulbecco’s 
modified eagle medium (DMEM) containing glucose, L-glutamine, and sodium pyruvate, 
supplemented with 10% fetal bovine serum, 0.1% MEM non-essential amino acid, 6mM 
HEPES, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in an atmosphere of 
5% CO2 and 95% air. The cells were kept subcultured at 70-90% confluency and media 
was changed every 3 days. For initial cytotoxicity experiments, cells utilized were 
between 15 and 50. Subcultured cells were placed in 6-well plates with the medium to 
obtain 250,000 cells/mL. The total volume was 2 mL in each well. Cells were grown for 
21 – 24 days before use. Before the experiment, cells were cultured with pH 6.5 Hanks’ 
Blank Balanced Solution (HBSS) (9.8 g/L Hanks’ Blank Salt Solution powder, 0.37 g/L 
sodium bicarbonate, and 2.86 g/L HEPES) for 1 hour. The filtered, post-digested aqueous 
phase of nanoemulsion samples were put on the wells after the HBSS was removed. 
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Samples were diluted from 100 – 12.5% with pH 6.5 HBSS. Photos were taken at times 
specified (0.5 – 8 h) to examine cell viability. 
6.3 Results and Discussion 
 
6.3.1 Fasted vs. Fed-Digestion and Bioaccessibility 
 
Statistical analysis of the fasted vs. fed state could not be performed because 
results for the fed state were from duplicate samples, while fasted state results were from 
triplicate samples. Instead, I detailed trends between the fasted and fed state.  The %BIO 
of nanoemulsions subjected to the fed state, with comparison to the fasted state, are seen 
in Table 12. Percent lipid digested is also noted: 
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Conditions 1% 
Droplet 
Concentration 
1.5% 
Droplet 
Concentration 
2% 
Droplet 
Concentration 
Fasted-%BIO 20 ± 10 40 ± 6 41 ± 4 
Fasted-% Lipid 
Digested 
92 ± 9 80 ± 9 68 ± 6 
Fed-%BIO 48 ± 1 56 ± 3 --- 
Fed-% Lipid 
Digested 
99 ± 8 94 ± 3 82 ± 5 
(A) LCT 
Conditions 1% 
Droplet 
Concentration 
1.5% 
Droplet 
Concentration 
2% 
Droplet 
Concentration 
Fasted-%BIO 8 ± 1 20 ± 7 58 ± 6 
Fasted-% Lipid 
Digested 
135 ± 9 120 ± 6 113 ± 6 
Fed-%BIO 28 ± 1 40 ± 3 58 ± 1 
Fed-% Lipid 
Digested 
124 ± 4 121 ± 4 111 ± 1 
(B) MCT 
Table 12: Effect of digestion state on %BIO. Results for the fed state are reported as 
the average of two measurements on freshly prepared samples, while results for the fasted 
state are reported as the average of three measurements. 
 
The results for 2% LCT were not able to be produced because the middle layer after the 
first wash with chloroform (see Figure 16) was too thick to accurately collect the bottom 
chloroform layer containing curcumin.  
As seen in Table 12, in vitro digestion of curcumin-containing emulsions in the 
simulated fed state showed a trend of increasing %BIO as droplet concentration 
increased. This could be due to several factors. First, the increased bile concentration (20 
mg/mL vs. 5 mg/mL for fasted) could increase the solubilization capacity of digestion 
products and increase the potential number of mixed carrier products able to encapsulate 
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curcumin. Second, the increased amount of lipase (2.4 mg/mL vs. 1.6 mg/mL for fasted) 
could hydrolyze fatty acid chains at the oil:water interface at an increased extent. Third, 
there could be an additive combination between bile and lipase. Increased lipase 
concentration can hydrolyze triacylglycerols at a faster rate in the fed state and the 
increased bile concentration can solubilize and remove the released FFA’s from the 
oil:water interface at a faster rate than the fed state. This allows greater access to the 
interface for lipase. To discover which explanation is more likely, it is necessary to see 
the titration profiles to examine initial digestion rate and eventual digestion extent. These 
are seen in Figure 21: 
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Figure 21: Effect of feeding state on digestion extent. Lipid concentrations 
(percentages) with “FA” were titrated with fasted state conditions, while concentrations 
with “FE” were titrated with fed state conditions. Results for the fed state are reported as 
the average of two measurements on freshly prepared samples, while results for the fasted 
state are reported as the average of three measurements. 
 
As seen in Figure 21, LCT had a higher digestion extent in the fed state vs. the fasted 
state at each lipid concentration, while MCT showed an opposite trend. In both cases, 
initial digestion rate was faster for fasted conditions. The most likely cause for LCT’s 
results (Fig. 21A) was the increased concentration of bile in the fed state solubilizing and 
removing digestion products from the oil:water interface, which allowed lipase greater 
access to the interface to hydrolyze emulsion droplets. The presence of released long 
chain FFA’s in solution can have an impact on digestion extent as results from titrations 
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performed with fasted conditions (Fig. 11) showed that LCT had the lowest digestion 
extent. The higher extent of long chain lipid digestion with greater bile salt 
concentrations is in agreement with previous studies (Borgstro.B and Erlanson 1973; 
Alvarez and Stella 1989; MacGregor, Embleton et al. 1997). For initial digestion rate in 
the fed state (Fig. 21A), there is an early period of some hydrolysis (0 – 800 s) followed 
by a period of rapid hydrolysis (800 – 2000 s). This effect is most likely due to droplet 
flocculation, which minimizes the surface area of droplets that lipase can act upon. 
Indeed, the sample looked turbid and precipitates were seen as the experiment initially 
started. As time progressed, the solution appeared less turbid as lipase was able to 
hydrolyze the nanoemulsion droplets and many of those products were solubilized in 
solution. So, initially, the released long chain FFA’s would limit access of lipase to the 
oil:water interface. As digestion continued, the higher concentration of bile and lipase 
would result in a higher efficiency at solubilizing digestion products and greater enzyme 
activity to hydrolyze emulsion droplets. 
Results for MCT (Fig. 21B) illustrated another, different effect that bile can have 
on digestion. Fasted conditions produced a slightly higher digestion extent than fed 
conditions and this can be due to having a high concentration of bile in solution that 
interfered with lipase access to the oil:water interface. It has been previously shown that 
increased bile concentrations can inhibit lipase activity by mixed micelles forming 
alternate binding sites for co-lipase, which can diminish binding of pancreatic lipase to 
the oil:water interface (Patton and Carey 1981). This interference can also explain the 
higher initial digestion rates for nanoemulsions at the fasted state. 
The PSD of fasted vs. fed (unfiltered) samples is seen in Table 10: 
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Droplet 
Concentration 
(%) 
Z-average 
(nm) - 
Fasted 
PDI (nm) - 
Fasted 
Z-average 
(nm) - 
Fed 
PDI (nm) - 
Fed 
1 99 ± 14 0.26 ± 0.03 159 ± 17 0.22 ± 0.05 
1.5 113 ± 5 0.37 ± 0.18 137 ± 13 0.29 ± 0.02 
2 161 ± 10 0.42 ± 0.09 125 ± 11 0.28 ± 0.08 
(A) LCT 
 
Droplet 
Concentration 
(%) 
Z-average 
(nm) - 
Fasted 
PDI (nm) - 
Fasted 
Z-average 
(nm) - 
Fed 
PDI (nm) - 
Fed 
1 161 ± 39 0.51 ± 0.08 94 ± 3 0.27 ± 0.01 
1.5 121 ± 13 0.20 ± 0.01 101 ± 7 0.30 ± 0.06 
2 68 ± 1 0.30 ± 0.04 105 ± 6 0.27 ± 0.02 
(B) MCT 
Table 13: Effect of digestion state on PSD. Samples of post-digested aqueous phase 
were analyzed unfiltered. Results are reported as the average of at least two 
measurements on freshly prepared samples. 
 
As seen in Table 13, there are some trends between the fasted and fed state. For LCT, the 
PDI for the fed state was smaller at each droplet concentration than the fasted state. For 
MCT, Z-average and PDI values in the fed state were similar at each droplet 
concentration. However, these trends do not seem to explain differences in %BIO results 
seen in Table 12. 
If Equation 6 was applied to the LCT results to account for 100% digestion 
(assuming curcumin % BIO is proportional to digestion extent), those results are seen in 
Table 14: 
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Droplet 
Concentration 
(%) 
%BIO Fasted 
(%) 
%BIO Fed 
(%) 
1 22 20 
1.5 50 60 
2 60 --- 
Table 14: Theoretical %BIO if total digestion is achieved. These do not take standard 
deviation into account, just average values. 
 
There was no data for 2% droplet concentration because the middle oil layer produced 
after centrifugation on the first wash with chloroform (Fig. 16) was too thick to be 
removed effectively to be able to isolate the bottom chloroform layer. Multiple attempts 
produced curcumin-containing chloroform layers interspersed with solids that made UV-
VIS readings unreliable. The unattained data was crucial because it would have shed 
insight on the limitations of my nanoemulsion delivery system in terms of %BIO of 
curcumin. A %BIO value significantly higher then 60% would have shown that 
bioaccessibility was measurably enhanced by fed conditions. If the value would have 
been similar to 60%, then we would know the limitations of the nanoemulsion delivery 
system and then be able to formulate ways to increase %BIO of curcumin. Even in the 
fed state for MCT (2% droplet concentration; Table 12B), the maximum theoretical 
%BIO (assuming curcumin %BIO is dependent on digestion extent) was approximately 
58%, a value similar to maximum %BIO values seen in Tables 6 and 10.  
Results for the fasted vs. fed state need to be standardized because some may say 
my fasted state was not accurate due to the high concentration of calcium (20 mmoles) 
used to make 100% digestion possible. The following values I propose to use as 
differentiating between the fasted and fed state were obtained from combining various 
conditions selected from literature (Zangenberg, Mullertz et al. 2001; Sek, Porter et al. 
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2002; Dahan and Hoffman 2008; Wright, Pietrangelo et al. 2008; Hu, Li et al. 2010). The 
proposed values are seen in Table 15: 
Experimental Parameter Fasted Fed 
pH 7 7 
Reaction Cell Volume 37.5 mL 37.5 mL 
Temperature 37 ºC 37 ºC 
Stirring Speed 4 s-1 4 s-1 
[NaOH] in Titration Unit 0.50 M 0.50 M 
Lipid content in Reaction Cell 300 mg 300 mg 
CaCl2 in Reaction Cell 5 mmoles 20 mmoles 
Bile Extract in Reaction Cell 5 mg/mL 20 mg/mL 
Pancreatin Lipase 0.4 mg/mL 2.4 mg/mL 
Table 15: Proposed values for studies involving fasted vs. fed state. 
 
Going forward, I believe these parameters would be best for using in studies that compare 
results of the fasted vs. fed state. My formulation (calcium = 20 mmoles; bile = 5 mg/mL; 
lipase = 1.6 mg/mL) was used because a set, lab-wide protocol with those concentrations 
for the in vitro digestion model was only determined as my initial work began. Of 
importance in the protocol was the ability to achieve 100% digestion of a sample. 
However, there is some variability in the conditions for the fasted and fed state. Even in 
the literature listed for Table 15, ranges were used for component concentrations. There 
would not be one set value for these states, so I selected the smallest (fasted) and largest 
(fed) concentrations to be the proposed values. 
6.3.2 Sonicated Emulsions-Digestion and Bioaccessibility 
 
The titration profile of sonicated emulsions, in the simulated fasted state, is seen 
in Figure 22: 
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Figure 22: Effect of oil type on digestion extent for sonicated emulsions. Results are 
reported as the average of three measurements on freshly prepared samples. 
 
Figure 22 followed similar results in that increasing droplet concentration resulted in 
lower digestion extent. Thus, this emulsion preparation method should not be noticeably 
different than the other methods (microfluidizer and blending only) used to prepare 
emulsions. The relationship between emulsion preparation method and digestion extent 
are seen in Table 16: 
Preparation 
Type 
Lipid 
Digested-1% 
(%) 
Lipid 
Digested-1.5% 
(%) 
Lipid 
Digested-2% 
(%) 
Nano 91 ± 9 80 ± 9 68 ± 6 
Conventional 98 ± 16 88 ± 8 73 ± 10 
Sonicated 121 ± 6 102 ± 7 82 ± 7 
(A) LCT 
 
Preparation 
Type 
Lipid 
Digested-1% 
(%) 
Lipid 
Digested-1.5% 
(%) 
Lipid 
Digested-2% 
(%) 
Nano 135 ± 9 120 ± 6 113 ± 6 
Conventional 139 ± 9 132 ± 13 123 ± 8 
Sonicated 155 ± 19 158 ± 18 148 ± 8 
(B) MCT 
 
Table 16: Effect of emulsion preparation method on digestion extent. Results are 
reported as the average of three measurements on freshly prepared samples. 
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For LCT, each preparation method showed a trend of increasing droplet concentration 
resulting in a decrease in digestion extent. Sonicated emulsions had the highest digestion 
extent at all droplet concentrations, but this could be due to differences in pancreatic 
lipase activity on an experiment-by-experiment basis. Pancreatic lipase is a mixture of at 
least three distinct lipolytic enzymes (Reis, Holmberg et al. 2009), so activity could 
change slightly. Droplet size should not be the reason for the results seen in Table 16 
because sonicated emulsions produced droplet sizes (200 – 600 nm) in between 
nanoemulsions and conventional emulsions. If digestion was dependent emulsion droplet 
size, with the trend seen between nanoemulsions and conventional emulsions, sonicated 
emulsions would digest to an extent between the other two preparation methods and not 
to a much higher extent. For MCT, sonicated emulsions deviated from other preparation 
methods because all three droplet concentrations produced similar extents of digestion.  
The PSD of sonicated emulsions are seen in Table 17: 
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Droplet 
Concentration 
(%) 
Z-average 
(nm) 
PDI 
(nm) 
1 114 ± 7 0.30 ± 0.04 
1.5 151 ± 11 0.29 ± 11 
2 146 ± 5 0.21 ± 0.01 
(A) LCT 
 
Droplet 
Concentration 
(%) 
Z-average 
(nm) 
PDI 
(nm) 
1 130 ± 33 0.29 ± 0.06 
1.5 113 ± 15 0.19 ± 0.02 
2 87 ± 24 0.29 ± 0.09 
(B) MCT 
Table 17: PSD of sonicated emulsions. Results are reported as the average of three 
measurements on freshly prepared samples. 
 
There was no statistical significance between particle size and droplet concentration for 
LCT and MCT. 
The %BIO of the sonicated nanoemulsions is seen in Table 18: 
Oil Type 1% 
Droplet 
Concentration 
1.5% 
Droplet 
Concentration 
2% 
Droplet 
Concentration 
LCT 50 ± 6 59 ± 3 53 ± 11 
MCT 5 ± 1 28 ± 8* 68 ± 5* 
Table 18: Effect of increased droplet concentration on %BIO of sonicated 
emulsions. Results with “*” were statistically different from the 1% sample. Results are 
reported as the average of three measurements on freshly prepared samples. 
 
If Equation 6 was applied to the results to account for 100% digestion (assuming 
curcumin % BIO is proportional to digestion extent), those results are seen in Table 19: 
 91 
 
Droplet 
Concentration 
(%) 
%BIO MCT 
(%) 
%BIO LCT 
(%) 
1 5 50 
1.5 28 59 
2 68 65 
Table 19: Theoretical maximum %BIO for sonicated emulsions. These do not take 
standard deviation into account, just average values. 
 
As seen in Table 18, the addition of available phospholipids increased %BIO of curcumin 
in MCT in a statistically significant manner, but not for LCT. MCT produced the highest 
%BIO between the oils. For LCT, addition of lipid produced only slightly higher %BIO 
that was not proportional to the greater amount of lipid present. With long chain FFA’s, 
there may be conflicting processes that result when high lipid concentrations are present 
that inhibit the ability to increase the amount of mixed bile salt micelles to incorporate 
curcumin in the aqueous phase. These experiments simulated fasted conditions, but the 
relationship of additional lipid only slightly increasing %BIO was not seen for the other 
emulsion preparations, nanoemulsion vs. conventional emulsion, that simulated fasted 
conditions (Table 11A). For those samples, an increase from 1 to 1.5% droplet 
concentration produced a sizable increase in %BIO and an increase from 1.5 to 2% 
showed %BIO values that were similar to each other. The latter trend remained for the 
sonicated emulsions, but the former trend (large %BIO increase from 1 to 1.5%) was not 
seen. 
As seen in Table 19, there seems to be a theoretical maximum %BIO for 
curcumin in the 60th percentile range. Sonicated emulsions were made in a similar 
fashion to nanoemulsions with a two-step homogenization procedure. During this time 
the microfluidizer was not operational, so this new method of making nanoemulsions was 
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adopted. While slightly different from nanoemulsions produced with the microfluidizer, 
the emulsions produced were in the 200 – 600 nm range and there was no correlation 
between oil type and differing droplet size for sonicated emulsions. The trend of 
increased lipid leading to increased %BIO for MCT was previously seen for the other 
emulsion preparations, nanoemulsion vs. conventional emulsion, also simulating fasted 
conditions (Table 11B).  The results from Table 17 suggested that more hydrolyzed 
medium chain FFA’s, as compared to long chain, are needed to self-assemble into mixed 
bile salt micelles that contain curcumin because MCT always produced >100% digestion 
at each droplet concentration. LCT rarely produced 100% digestion and, yet, the 
theoretical %BIO for LCT was often found to be similar to MCT (Tables 6, 14, and 19) 
in that %BIO was in the 60th percentile range. It must also be noted the results from 
Figure 16 where centrifuging after the first wash of chloroform produced an oil layer that 
I hypothesize consisted of FFA’s, monoglycerides, diglycerides, and calcium precipitated 
digestion products. MCT samples with the first wash of chloroform produced a thin, 
delicate layer between the aqueous and chloroform layers, which would be expected if 
complete digestion of the emulsion droplets was achieved. If LCT can have a theoretical 
maximum %BIO similar to MCT, with many more digestion products not formed into 
curcumin-containing micelles, then it can be reasoned that these digestion products have 
the potential to form micelles, vesicles, and/or liposomes under more favorable 
conditions. With those available products being able to form micelles, vesicles, and/or 
liposomes, LCT seems to have the potential to be the superior oil capable of producing 
the highest %BIO of curcumin. However, more work needs to be done to examine the 
 93 
precipitated layer (Fig. 16) and to formulate conditions that would allow these digestion 
products to become potential carriers for curcumin after digestion. 
6.3.3 Caco-2 Cell Viability 
 
I calculated %BIO for curcumin, but that value was not the same as the eventual 
bioavailability for curcumin, i.e. the amount of curcumin that ends up in systemic 
circulation. The amount that ends up in the bloodstream is most likely less than the 
amount that is bioaccessible in the small intestine because there are metabolic and 
absorption processes that the mixed micelles are subject to before the curcumin can get to 
the bloodstream (Fig. 2). Specific processes can include metabolism via the liver and 
bacteria in the small intestine. Caco-2 cell models have been used for predicting eventual 
bioavailability because mature, differentiated cells have the same characteristics as 
enterocyte cells in the small intestine.  
 Uptake experiments with Caco-2 cells are commonly used for determining 
eventual concentration of lipophilic drugs. The drug would absorb from the apical side to 
the basolateral side. Unfortunately, I have had much trouble finding a suitable medium 
for the curcumin because the filtered post-digestion solution killed the Caco-2 cells in a 
matter of hours as seen in Table 20: 
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 0.5 Hr 1 Hr 2 Hr 4 Hr 8 Hr 
Control Alive Alive Alive Alive Alive 
100% Dead Dead Dead Dead Dead 
75% Dead Dead Dead Dead Dead 
50% Dead Dead Dead Dead Dead 
25% Alive Mix Dead Dead Dead 
12.5% Alive Alive Alive Mix Mix 
(A) LCT 
 
 0.5 Hr 1 Hr 2 Hr 4 Hr 8 Hr 
Control Alive Alive Alive Alive Alive 
100% Dead Dead Dead Dead Dead 
75% Dead Dead Dead Dead Dead 
50% Dead Dead Dead Dead Dead 
25% Dead Dead Dead Dead Dead 
12.5% Alive Alive Alive Alive Mix 
(B) MCT 
 
Table 20: Caco-2 cell viability with post-digested nanoemulsion. The percentages on 
the left column are the dilutions of the filtered post-digestion solution. 
 
 I hypothesized that the bile concentration was too large and that is what caused 
the cells to die. Bile acts as a detergent and this property caused the cells to be 
transplanted from their positions on the cell plate, which is a result of cell death. Previous 
studies have found that various kinds of surface active molecules may decrease the 
viability of model colon cancer cells, including bile salts, phospholipids, anionic 
surfactants, cationic surfactants, and nonionic surfactants (Boulenc, Breul et al. 1995; 
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Dimitrijevic, Shaw et al. 2000; Ingels and Augustijns 2003). Viable (alive) vs. dead cells 
are seen in Figure 23: 
 
 
ALIVE       DEAD   
 
Figure 23: Photographs of Caco-2 cell viability.   
 
As seen in Figure 23, dead cells did not show the differentiation and 
compartmentalization of viable cells. More studies were done to see the effect of bile 
concentration on Caco-2 cell viability and these results are seen in Table 21: 
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 0.5 Hr 1 Hr 2 Hr 4 Hr 8 Hr 
Control Alive Alive Alive Alive Alive 
100% Dead Dead Dead Dead Dead 
75% Mix Dead Dead Dead Dead 
50% Alive Mix Dead Dead Dead 
25% Alive Alive Alive Alive Mix 
12.5% Alive Alive Alive Alive Mix 
(A) 5 mg/mL Bile 
 
 0.5 Hr 1 Hr 2 Hr 4 Hr 8 Hr 
Control Alive Alive Alive Alive Alive 
100% Alive Mix Dead Dead Dead 
75% Alive Alive Dead Dead Dead 
50% Alive Alive Mix Dead Dead 
25% Alive Alive Alive Mix Dead 
12.5% Alive Alive Alive Alive Alive 
(B) 2.4 mg/mL Bile 
 
 0.5 Hr 1 Hr 2 Hr 4 Hr 8 Hr 
Control Alive Alive Alive Alive Alive 
100% Dead Dead Dead Dead Dead 
75% Alive Alive Dead Dead Dead 
50% Alive Alive Alive Mix Dead 
25% Alive Alive Alive Alive Mix 
12.5% Alive Alive Alive Alive Alive 
(C) 0.4 mg/mL Bile 
 
Table 21: Effect of bile on Caco-2 cell viability. Each sample has 2% MCT with 0.15% 
curcumin post-digested solution as the beginning nanoemulsion. Lipase (1.6 mg/mL) and 
calcium (20 mmoles) concentration do not change.   
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As seen in Table 20, as bile concentration increased, the amount of dead cells increased 
at a faster time period. Previous studies have used bile concentrations from 0.4 – 12 
mg/mL (Garrett, Failla et al. 1999; Liu, Glahn et al. 2004) with similar growing 
conditions and applications to Caco-2 cells. More studies need to be performed to obtain 
viable Caco-2 cells to determine uptake, which is similar to determining eventual 
bioavailability. This will show a more complete picture of the behavior of nanoemulsion 
delivery systems of lipophilic drugs during digestion.  
6.4 Conclusions 
 
 Digestion rate, extent, particle size, and %BIO were determined for the fed state 
and were compared to the fasted state. Particle size showed no trend between the fasted 
and fed state. %BIO of LCT increased in the fasted state, but MCT produced no such 
trend. LCT had a higher digestion extent in the fed state vs. the fasted state at each lipid 
concentration, while MCT showed an opposite trend. In both cases, initial digestion rate 
was faster for fasted conditions.  
 Sonicated emulsions were produced to mimic nanoemulsions, while the 
microfluidizer was unavailable. These emulsions were used for an alternative method to 
obtaining %BIO, as the amount of curcumin did not change for the samples, but amount 
of lipid changed. No definitive trends for particle size were seen and digestion extent was 
greater than prepared nanoemulsions and conventional emulsions. However, this could be 
due more to the lipase activity during the time these experiments were performed rather 
than digestion affinity based on droplet size.  
%BIO of MCT increased as lipid concentration increased, but LCT showed no 
such trend for sonicated emulsions. The theoretical %BIO of MCT and LCT were similar 
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and this suggested that there could be a limit to %BIO that an emulsion-based delivery 
system could provide. However, the aqueous phase of LCT needs to be examined further 
to see if there are available digestion products such as FFA’s, monoglycerides, and 
diglycerides that have the potential to form micelles, vesicles, and/or liposomes to 
become carriers for curcumin. This potential could increase %BIO and suggest that LCT 
has a higher potential %BIO than MCT. 
Caco-2 cells are used for predicting eventual bioavailability. I have had much 
trouble with bile acting as a detergent and killing the cells. More work must be performed 
to obtain a model that withstands the detergent abilities of bile. This model would also 
need appropriate concentrations of curcumin to be available, so proper determination of 
curcumin bioavailability after uptake is possible. 
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